levonorgestrel has been researched along with desogestrel in 315 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (12.70) | 18.7374 |
| 1990's | 85 (26.98) | 18.2507 |
| 2000's | 86 (27.30) | 29.6817 |
| 2010's | 91 (28.89) | 24.3611 |
| 2020's | 13 (4.13) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Bäckström, T; Cavalli-Björkman, B; Hansson-Malmström, Y; Lindhe, BA; Nordenström, S | 1 |
| Felton, C; Godsland, IF; Patel, A; Proudler, A; Walton, C; Wynn, V | 1 |
| Kauppinen-Mäkelin, R; Kuusi, T; Tikkanen, MJ; Ylikorkala, O | 1 |
| Chen, JK; Fan, BC; Fotherby, K; He, ML; Li, LM; Rekers, H; Song, S; Yang, PJ | 1 |
| Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Csemiczky, G; Landgren, BM | 1 |
| Laine, M; Ojanotko-Harri, A; Pienihäkkinen, K; Tenovuo, J | 1 |
| Ho, PC; Kwan, MS; Liu, WT | 1 |
| Johansson, E; Odlind, V; Olsson, SE | 1 |
| Hahn, DW; McGuire, JL; Phillips, A | 1 |
| Fotherby, K | 1 |
| Kloosterboer, HJ; Rekers, H | 1 |
| Roy, S; Stanczyk, FZ | 1 |
| Anyaoku, V; Crook, D; Devenport, M; Felton, C; Godsland, IF; Lees, B; Proudler, T; Simpson, R; Wynn, V | 1 |
| Bauer, K; Jürgensen, R; Kaffarnik, H; Steinmetz, A | 1 |
| Assendorp, R; Bergink, W; Kloosterboer, L; Qvist, I; van Lier, W; Voortman, G | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Edén, S; Karlsson, R; von Schoultz, B | 1 |
| Juchem, M; Pollow, K | 1 |
| Kivinén, S; Palatsi, R; Reinilä, M | 1 |
| Nilsson, B; von Schoultz, B | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Bonnar, J; Carroll, E; Daly, L | 1 |
| Gahn, G; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Gahn, G; Gross, W; Kuhl, H; März, W; Romberg, G; Taubert, HD | 1 |
| Ide, P; Wynants, P | 1 |
| Mall-Haefeli, M | 1 |
| Kloosterboer, HJ; van den Ende, A; van Wayjen, RG | 1 |
| Doornebos, CM; Hamerlynck, JV; Muntendam, P; Vollebregt, JA | 1 |
| Hoppe, G | 1 |
| Bonnar, J | 1 |
| Rabe, T; Runnebaum, B | 1 |
| Kuusi, T; Tikkanen, MJ; Viinikka, L; Ylikorkala, O | 1 |
| Balestreri, R; Bertolini, S; Cordera, R; Croce, S; De Cecco, L; Elicio, N; Gapitanio, GL; Montagna, G; Saturnino, M | 1 |
| Erkkola, R; Grönroos, M; Järnström, S; Liukko, P; Näntö, V; Pakarinen, P | 1 |
| Bergink, EW; Erkkola, R; Liukko, P | 1 |
| Desager, JP; Gaspard, U; Harvengt, C; Lepot, M | 1 |
| Chailurkit, L; Phiromsawat, S; Rojanasakul, A; Sirimongkolkasem, R | 1 |
| Benraad, TJ; Meulenberg, PM; Ross, HA; Swinkels, LM | 1 |
| Anderson, DC; Evans, A; Mamtora, H; Mavroudis, K; Robertson, WR | 1 |
| Kloosterboer, HJ; Turpijn, EW; Vonk-Noordegraaf, CA | 1 |
| Demeter, J; Gáti, I; Gerö, G; Rákóczi, I | 1 |
| Kuusi, T; Nikkilä, EA; Sipinen, S; Tikkanen, MJ | 2 |
| Buret, J; Gaspard, UJ; Gillain, D; Lambotte, R; Romus, MA | 1 |
| Crona, N; Samsioe, G; Silfverstolpe, G | 2 |
| Käär, K; Ruokonen, A | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Bergink, EW; Borglin, NE; Klottrup, P; Liukko, P | 1 |
| Samsioe, G | 1 |
| Baumgarten, S; Hammerstein, J; Römmler, A; Schwartz, U | 1 |
| Alapiessa, U; Lund, L; Nummi, S; Ruokonen, A; Viinikka, L | 1 |
| Andersen, NB; Andersen, RF; Bredesgaard, P; Cullberg, G; Ernerot, H; Fanøe, E; Fylling, P; Haack-Sørensen, PE; Klottrup, P; Pedersen, JH; Samsioe, G; Sandager, T | 1 |
| de Visser, J; van der Vies, J | 1 |
| Demey-Ponsart, E; Duvivier, J; Franchimont, P; Gaspard, UJ; Gillain, D; Romus, MA | 1 |
| Hammond, GL; Langley, MS; Lund, L; Nummi, S; Robinson, PA | 1 |
| Bergink, EW; Kloosterboer, HJ; Lund, L; Nummi, S | 1 |
| Crona, N; Enk, L; Samsioe, G; Silfverstolpe, G | 1 |
| Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C | 1 |
| Hau, J; Nielsen, CH; Poulsen, HK; Teisner, B; Thorsen, P; Westergaard, JG | 1 |
| Bielfeld, P; Conrad, M; Graf, M; Krüssel, JS; Rudolf, K | 1 |
| Crook, D; Devenport, M; Godsland, IF; Wynn, V | 1 |
| Croxatto, H; Diaz, S; Peralta, O | 1 |
| Dahlen, GH; Erkkola, R; Porkka, KV; Raitakari, OT; Taimela, S; Viikari, JS | 1 |
| Christiansen, C; Marslew, U; Munk-Nielsen, N; Nilas, L; Riis, BJ | 1 |
| Coutinho, EM; Ladipo, O | 1 |
| Kuhnz, W; Schütt, B; Woloszczak, R | 1 |
| de Vries Robles-Korsen, TJ; Hemrika, DJ; Kennedy, JC; Schoemaker, J; Slaats, EH | 2 |
| Alvarez, F; Bassol, S; Brache, V; Coutinho, EM; da Silva, AR; de Acosta, OM; de Souza, JC; Garza Flores, J; Santo, R; Vasquez-Estrada, L | 1 |
| Byrjalsen, I; Christiansen, C; Haarbo, J | 1 |
| Bounds, W; Guillebaud, J; Newman, B; Nichols, M; Robinson, G | 1 |
| Fraser, IS; Markham, R; Peek, MJ | 1 |
| Dieben, TO; Geurts, TB; Hellstern, P; Weinges, KF; Wenzel, E | 1 |
| Joosten, JW; Kloosterboer, HJ; Schoonen, WG | 2 |
| Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D | 1 |
| Jick, H; Jick, S; Myers, MW; Vasilakis, C | 1 |
| Farmer, RD; Lawrenson, R | 1 |
| Fjalland, B; Moller, BM; Moller, SE; Olesen, M | 1 |
| Bennink, HC; Dieben, T; Exalto, N; van der Does, J | 1 |
| Graff-Iversen, S; Stensvold, I; Tverdal, A | 1 |
| Bruppacher, R; Heinemann, LA; Lewis, MA; MacRae, KD; Spitzer, WO | 1 |
| Lippert, TH; Lorkowski, G; Mück, AO; Seeger, H; Teichmann, AT | 1 |
| Roke, C | 1 |
| Lidegaard, O | 1 |
| Schwingl, PJ; Shelton, J | 1 |
| Weiss, NS | 1 |
| Bloemenkamp, KW; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP | 1 |
| Hamulyak, K; Heijnen, P; Hemker, HC; Nicolaes, GA; Rosing, J; Tans, G; Thomassen, MC; van der Ploeg, PM; van Oerle, R | 1 |
| Diffey, B; O'Dea, K; Piers, LS; Soares, MJ | 1 |
| Alexandersen, P; Christiansen, C; Haarbo, J | 1 |
| Anawalt, BA; Bremner, WJ; Matsumoto, AM; McLachlan, RI; Wreford, NG; Zhengwei, Y | 1 |
| Asplund, B; Coelingh Bennink, H; Mäkäräinen, L; Tuomivaara, L; van Beek, A | 1 |
| Engström, BE; Karlsson, FA; Wide, L | 1 |
| Bühler, K; Coelingh Bennink, HJ; Geurts, TB; Howie, H; Korver, T; Winkler, UH | 1 |
| Bennink, HC; Egberg, N; Gunnervik, C; Hirvonen, E; Hulkko, S; Larsson-Cohn, U; van Beek, A | 1 |
| Berg, G; Brenner, H; Kohlmeier, L | 1 |
| Bennink, HC; Mascarenhas, L; Newton, J; van Beek, A | 2 |
| Weiss, G | 1 |
| Edwards, JE; Moore, A | 1 |
| Mascarenhas, L | 1 |
| Croxatto, HB; Mäkäräinen, L | 1 |
| Affandi, B | 1 |
| Urbancsek, J | 1 |
| Coelingh Bennink, H; Dieben, T; Killick, SR; Rice, CF | 1 |
| Cheung, MC; Knopp, RH; Walden, CE | 1 |
| Farmer, RD; Lawrenson, R; Leydon, GM; Todd, J; Williams, TJ | 1 |
| Chang, CL; Farley, TM; Marmot, MG; Meirik, O; Poulter, NR | 1 |
| Jick, H; Jick, SS; Myers, MW | 1 |
| Kaper, RF; Qian, SZ; Sang, GW; Zheng, HM; Zheng, SR | 1 |
| Bouma, BN; Büller, HR; Christella, M; Curvers, J; Meijers, JC; Middeldorp, S; Nicolaes, GA; Prins, MH; Rosing, J; Tans, G; Thomassen, LG | 1 |
| Affandi, B; Korver, T; Suherman, SK | 1 |
| Cusson, J; Heinemann, L; Lewis, M; Rainville, B; Spitzer, WO; Suissa, S | 1 |
| Buicu, C; Gaspard, U; van den Brûle, F | 1 |
| Walling, M | 1 |
| Helmerhorst, F; Vandenbroucke, JP | 1 |
| Kluft, C | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; van den Ende, AE; van Enk, A | 1 |
| Bouma, BN; Büller, HR; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Tekelenburg, W; van den Ende, AE | 1 |
| Bouma, BN; Büller, HR; Curvers, J; Meijers, JC; Middeldorp, S; Prins, MH; Rosing, J; Tans, G; Thomassen, MC | 1 |
| Colau, JC | 1 |
| Busse, R; Herkert, O; Kuhl, H; Schini-Kerth, VB | 1 |
| Anawalt, BD; Bremner, WJ; Coelingh-Bennink, HJ; Herbst, KL; Matsumoto, AM; Mulders, TM | 1 |
| Rissanen, P | 1 |
| Bennink, HJ; Biswas, A; Korver, T; Ratnam, SS; Viegas, OA | 1 |
| Meurer, LN; Slawson, JG | 1 |
| Gabriel, HH; Hilberg, T; Müller-Berghaus, G; Nowacki, PE | 1 |
| Broyles, FE; Chandler, WL; Cheung, M; Knopp, RH; Marcovina, S; Moore, K | 1 |
| Biswas, A; Coeling Bennink, HJ; Korver, T; Ratnam, SS; Viegas, OA | 1 |
| Bounds, W; Furs , SA; Guillebaud, J; Johnson, J; Machin, SJ; Mackie, IJ; Piegsa, K | 1 |
| Agren, U; Dieben, T; Kivelä, A; Ruuskanen, M | 1 |
| Petersen, KR; Poulsen, EF | 1 |
| Bijaoui, S; Dupont, G; Foulon, T; Groslambert, P; Laporte, F; Payen, N; Roland, F | 1 |
| Brautigam, J; Brueckner, T; Michels, W; Schleussner, E | 1 |
| Berlin, JA; Hennessy, S; Kinman, JL; Marcus, SM; Margolis, DJ; Strom, BL | 1 |
| Darney, PD; Meckstroth, KR | 1 |
| Harwood, B; Mishell, DR | 1 |
| Dulícek, P | 1 |
| Algra, A; Cats, VM; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Tumolo, J | 1 |
| Barkfeldt, J; Dieben, T; Virkkunen, A | 1 |
| Bremme, K; Hamsten, A; Silveira, A; van Rooijen, M; von Schoultz, B | 1 |
| Algra, A; Bouma, BN; Grobbee, DE; Kemmeren, JM; Meijers, JC | 2 |
| Meirik, O | 1 |
| Milsom, I; Odlind, V; Ostlund, I; Persson, E; von Schoultz, B | 1 |
| Algra, A; Grobbee, DE; Kemmeren, JM | 1 |
| Algra, A; Bollen, EL; Helmerhorst, FM; Kemmeren, JM; Rosendaal, FR; Tanis, BC; van den Bosch, MA; van der Graaf, Y | 1 |
| Milsom, I; Odlind, V; Persson, I; Victor, A | 1 |
| Black, C; Jick, H; Kaye, JA | 1 |
| Keder, LM | 1 |
| Olsson, SE | 1 |
| Ishak, R | 1 |
| Chen, JK; Gui, YL; He, ML; Li, LM; Yang, PJ | 1 |
| Baharum, Y; Khalid, H; Roshidah, I | 1 |
| Mascarenhas, L; Varma, R | 1 |
| Porter, C; Rees, MC | 1 |
| Breitkopf, DM; Nagamani, M; Rosen, MP; Young, SL | 1 |
| Breitkopf, DM; Nagamani, M; Rosen, MP | 1 |
| Alexandersen, P; Christiansen, C; Haarbo, J; Jespersen, J; Skouby, SO; Zandberg, P | 1 |
| Du, MK; Yao, XY | 1 |
| Laine, K; Lundgren, S; Palovaara, S; Pelkonen, O; Uusitalo, J | 1 |
| Algra, A; Bouma, BN; Curvers, J; Grobbee, DE; Kemmeren, JM; Meijers, JC; Rosing, J; Tans, G | 1 |
| Biswas, A; Roy, AC; Viegas, OA | 1 |
| Cohen, EB; Rossen, NN | 1 |
| Benagiano, G; Primiero, FM | 1 |
| Kamischke, A; Nieschlag, E; Zitzmann, M | 1 |
| Anawalt, BD; Bremner, WJ; Matsumoto, AM; McLachlan, RI; Meriggiola, C; Pruysers, E; Robertson, DM; Ugoni, A | 1 |
| Dieben, TO; Klimscheffskij, R; Tuppurainen, M; Venhola, M | 1 |
| Cedars, MI; Hughes, HD; Lynch, AM; Schlaff, WD; Smith, DL | 1 |
| Ferguson, H; Mulders, JA; Winkler, UH | 1 |
| Baerwald, AR; Olatunbosun, OA; Pierson, RA | 1 |
| Biswas, A; Biswas, S; Viegas, OA | 1 |
| Levine, JP | 1 |
| Guest, JF; Varney, SJ | 1 |
| Bouma, BN; Deguchi, H; Griffin, JH; Lee, YM; Middeldorp, S | 1 |
| Chatterjee, R; Oswal, A | 1 |
| Shulman, LP | 1 |
| Bray, JA; Bray, JD; Brown, EL; Ghatge, R; Horwitz, KB; Jacobsen, BM; Jelinsky, S; Lyttle, CR; Richer, JK; Saraf, K; Tunkey, C; Winneker, RC | 1 |
| Bahamondes, L; Dos Santos Fernandes, AM; Espejo-Arce, X; Lui-Filho, JF; Monteiro-Dantas, C; Perrotti, M; Petta, CA | 1 |
| Rajalakshmi, M | 1 |
| Szarewski, A | 1 |
| Jick, H; Jick, SS; Kaye, JA; Russmann, S | 1 |
| Cagiano, R; Sabatini, R | 1 |
| Jick, H; Jick, SS | 1 |
| Claeys, S; De Bodt, M; Van Cauwenberge, P; Van Lierde, KM | 1 |
| Egger, K; Erben, RG; Felsenberg, D; Hartard, M; Kleinmond, C; Luppa, P; Weissenbacher, ER; Wiseman, M; Zelger, O | 1 |
| Fraser, IS; Kaitu'u-Lino, TJ; Morison, NB; Salamonsen, LA; Zhang, J | 1 |
| Kubán, V; Matejícek, D | 1 |
| Al-Jefout, M; Fraser, IS; Palmer, J | 1 |
| Shulman, LP; Simon, M | 1 |
| Cowan, F; French, R; Power, J | 1 |
| Chandra, NC; Das, C; Ramakrishnan, G; Rana, A | 1 |
| Bertina, RM; Dahm, AE; Helmerhorst, FM; Rosendaal, FR; Rosing, J; Sandset, PM; van Vliet, HA | 1 |
| Fisher, AC; Kluft, C; LaGuardia, KD; Meijer, P | 1 |
| Mavranezouli, I | 1 |
| de Vernejoul, MC; Sarfati, J | 1 |
| Buono, MJ; Martin, JG | 1 |
| Bonnema, R; McNamara, MC; Spencer, AL | 1 |
| Stephenson, V | 1 |
| Dinger, J; Shapiro, S | 1 |
| Grimes, DA; Lopez, LM; O'Brien, PA; Raymond, EG | 2 |
| Freeman, S; Shulman, LP | 1 |
| Burke, AE; McDonald-Mosley, R | 1 |
| Höschen, K; Röhm, P; Winkler, UH | 1 |
| Weisberg, E | 1 |
| Güner, Z; Küçük, M; Odabaşi, AR; Sezer, SD; Yüksel, H | 1 |
| Handasyde, KA; Hynes, EF; Renfree, MB; Shaw, G | 1 |
| Sanam, M; Ziba, O | 1 |
| Bressler, B; Brophy, JM; Delaney, JA; Etminan, M | 1 |
| Cleuren, AC; Postmus, I; Reitsma, PH; van Vlijmen, BJ; Vos, HL | 1 |
| Lidegaard, Ø; Løkkegaard, E; Nielsen, LH; Skjeldestad, FE; Skovlund, CW | 1 |
| Voelker, R | 1 |
| Berg, E; Bremme, K; Hamad, RR; Stenflo, J; Strandberg, K | 1 |
| Dallay, D; Hanisch, JU; Inki, P; Omokanye, S; Short, M | 1 |
| Randel, A | 1 |
| Foldemo, A; Josefsson, A; Lindberg, M; Wiréhn, AB | 1 |
| Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF | 1 |
| Basha, M; Burrows, LJ; Goldstein, AT | 1 |
| Ali, M; Brache, V; Culwell, K; Habib, NA; Jackson, E; Meirik, O; Orawan, K; Ortayli, N; Schmidt, J | 1 |
| Abd Alhamid, M; Elyan, A; Ibrahim, A; Ibrahim, EA; Laban, M | 1 |
| Cannegieter, SC; Helmerhorst, FM; Lijfering, WM; Roach, RE; Rosendaal, FR; van Hylckama Vlieg, A | 1 |
| Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R | 1 |
| Bai, Y; Banga, AK; Kydonieus, A; Sachdeva, V | 1 |
| Bender, NM; Mishell, DR; Montoro, M; Najera, SO; Segall-Gutierrez, P; Stanczyk, FZ | 1 |
| Bateson, D; Briggs, P; McNamee, K | 1 |
| Allsworth, JE; Madden, T; Peipert, JF; Secura, GM; Vickery, Z; Zhao, Q | 1 |
| Amaral, E; Bahamondes, L; Bahamondes, MV; Magalhães, A; Mishell, DR; Modesto, W; Pinto e Silva, JL; Tilley, IB | 1 |
| Black, KI; Mwalwanda, CS | 1 |
| Bizior-Frymus, D; Dyja, R; Jonderko, K; Kamińska, M; Kasicka-Jonderko, A; Skałba, P | 1 |
| Kostev, K; Rashed, AN; Ziller, M; Ziller, V | 1 |
| Matthews, CM; Prescott, GM | 1 |
| Bateson, D; McGeechan, K; Mohapatra, L; Weisberg, E | 1 |
| Dallay, D; Inki, P; Omokanye, S; Short, M; Stauch, K | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
| Hel, Z; Huijbregts, RP; Michel, KG | 1 |
| Bahamondes, L; Bahamondes, MV; Modesto, W | 1 |
| Chiovato, L; Howard, B; Nappi, RE; Paoletti, AM; Ricciotti, N; Volpe, A; Weiss, H | 1 |
| Anderson, RA; Chao, J; Page, ST | 1 |
| Micks, E; Prager, S | 1 |
| Amies Oelschlager, AM; Debiec, KE; Mantrala, MD; Micks, EA; Nizamic, T; Prager, SW | 1 |
| Schreiber, CA; Sober, S | 1 |
| Buckel, CM; Madden, T; McNicholas, C; Mullersman, J; Peipert, JF; Secura, GM; Zhao, Q | 1 |
| Hathaway, M; Torres, L; Vollett-Krech, J; Wohltjen, H | 1 |
| Fraser, IS; McGeechan, K; Merki-Feld, GS; Weisberg, E | 1 |
| Berenson, AB; Hirth, JM; Tan, A | 1 |
| Maddipati, R; McNicholas, C; Peipert, JF; Swor, E; Zhao, Q | 1 |
| Howard, B; Hsieh, J; Kroll, R; Ricciotti, N; Seidman, L; Weiss, H | 1 |
| Chen, M; Gallo, MF; Grey, TW; Lopez, LM; Stuebe, AM; Truitt, ST | 1 |
| Diedrich, JT; Drey, EA; Harper, CC; Sokoloff, A; Steinauer, JE; Upadhyay, UD | 1 |
| Cagnacci, A; Di Carlo, C; Grandi, G; Napolitano, A; Palma, F; Romani, C; Zanin, R | 1 |
| Candido-Dos-Reis, FJ; Gonçalvez, TM; Máximo, MM; Nogueira, AA; Poli-Neto, OB; Rosa-E-Silva, JC; Silva, PS; Vieira, CS | 1 |
| Callahan, R; Halpern, V; Nanda, K; Yacobson, I | 1 |
| Ali, M; Bahamondes, L; Brache, V; Habib, N; Landoulsi, S; Meirik, O | 1 |
| Kovács-Kiss, D; Szabó, P; Zelkó, R | 1 |
| Apter, D; Briggs, P; Gemzell-Danielsson, K; Grunert, J; Lukkari-Lax, E; Rybowski, S; Tuppurainen, M | 1 |
| Dahiya, K; Dahiya, P; Dalal, M; Jain, S; Silan, V; Yadav, A | 1 |
| Skjeldestad, FE; Øvre-Eide, V | 1 |
| Benagiano, G; Bianchi, P; Brosens, I; Gordts, S; Guo, SW; Petraglia, F; Puttemans, P | 1 |
| Akin, A; Ali, M; Bahamondes, L; Brache, V; Habib, N; Hubacher, D; Landoulsi, S | 1 |
| Curtis, KM; Jatlaoui, TC; Riley, HEM | 1 |
| Goel, N; Priya, K; Rajaram, S | 1 |
| Madden, T; Omvig, K; Peipert, JF; Silva Dos Santos, PN | 1 |
| McNicholas, C; Peipert, JF; Swor, E; Wan, L | 1 |
| Gawron, LM; Law, A; Lynen, R; Sanders, JN; Turok, DK; Wen, L | 1 |
| Abe, J; Fukuda, A; Hane, Y; Hasegawa, S; Hatahira, H; Hirade, K; Kinosada, Y; Matsui, T; Motooka, Y; Naganuma, M; Nakamura, M; Sasaoka, S; Takahashi, Y | 1 |
| Petersen, KR; Ravn, P | 1 |
| Ali, M; Bahamondes, L; Bent Landoulsi, S | 1 |
| Buggio, L; Frattaruolo, MP; Ottolini, F; Roberto, A; Somigliana, E; Vercellini, P | 1 |
| Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F | 1 |
| Castillo Cañadas, AM; García Santos, F; Gómez García, MT; González de Merlo, G; González Mirasol, E; López Del Cerro, E; Serrano Diana, C | 1 |
| Banda, C; Chagomerana, M; Lemani, C; Nkambule, J; Talama, G; Tang, JH; Zgambo, W | 1 |
| Ali, M; Bahamondes, L; Brache, V; Habib, N | 1 |
| Goldstuck, ND; Le, HP | 1 |
| Bachelot, A; Dureau, P; Funck-Brentano, C; Germain, M; Hulot, JS; Lebourgeois, B; Salem, JE; Trégouët, DA; Voiriot, P | 1 |
| Ahmed, G; Lara, J; Meece, FA; Nair, H; Nickisch, K; Pollok, NE; Santhamma, B; Shaked, Z; Tekmal, RR; Zhao, C | 1 |
| Chen, L; Hu, J; Huang, Y; Wu, J; Zou, Y | 1 |
| Lavelanet, A; Thaxton, L | 1 |
| Bahamondes, L; Eloy, L; Margatho, D; Mota Carvalho, N | 1 |
| Hugon-Rodin, J; Plu-Bureau, G; Sabbagh, E | 1 |
| Bahamondes, L; Benetti-Pinto, CL; Carvalho, N; Cursino, K; Margatho, D | 1 |
| Baiamonte, L; Drobnis, EZ; Hope, TJ; Huang, L; Li, L; Mills, M; Quayle, AJ; Schust, DJ; Stark, M; Tu, J; Wang, W; Zhou, J | 1 |
| Brandão, ER | 1 |
| Allen, RH; Cohen, KE; Has, P; Matteson, KA | 1 |
| Akers, J; Augustine, MS; Buckner, LR; Drobnis, EZ; Hope, TJ; Mott, PD; Quayle, AJ; Rogers, LK; Schust, DJ | 1 |
| Bola-Oyebamiji, SB; Okunola, TO; Sowemimo, O | 1 |
| Baeten, JM; Blue, SW; Erikson, DW; Kelly, EJ; Kim, CJ; Kourtis, AP; Lingappa, JR; Mugo, N; Nanda, K; Patel, RC; Scarsi, KK; Stalter, RM; Tamraz, B; Thomas, KK | 1 |
| Baraitser, P; Battison, C; Cameron, S; Cameron, ST; Cowle, K; Forrest, M; Gilson, R; Glasier, A; Goulao, B; Johnstone, A; McDaid, L; McDonald, A; Morelli, A; Norrie, J; Patterson, S; Radley, A; Sally, D; Stephenson, JM; Stewart, N; Trussell, J | 1 |
| Gawron, LM; Gero, A; Kushner, KL; Sanders, JN; Turok, DK | 1 |
| Bahamondes, L; Carvalho, NM; Margatho, D | 1 |
| Lumbiganon, P; Pattanittum, P; Sangkomkamhang, US | 1 |
| Brown, J; Cicali, B; Schmidt, S; Sunaga, T | 1 |
| Bryson, AE; Cabral, HJ; Coles, MS | 1 |
| Crespi, S; Fabron, C; Farge, G; Lévy-Bachelot, L; Linet, T; Robert, J; Yang, JZ | 1 |
| McQuillan, SK; Rosenthal, MA | 1 |
| Brito, MB; da Silva, SBL; Maron, CC; Pinheiro, MSA; Trigo, ACM | 1 |
| Cheng, L; Nie, LK; Zhang, PH; Zou, HL | 1 |
| Burchardt, NA; Eliassen, AH; Fortner, RT; Kaaks, R; Rosner, B; Shafrir, AL; Tamimi, RM; Tworoger, SS | 1 |
| Braitmaier, M; Haug, U; Princk, C; Schink, T | 1 |
| Gibson, DM; Ko, PJ; Milad, MA; Radulovic, LL | 1 |
| Badda, M; Castillo, S; Catarino, R; Gezer-Dickschat, S; Lombardi Fäh, V; Thieringer, F; Tschudin, S; Viviano, M; Yaron, M | 1 |
48 review(s) available for levonorgestrel and desogestrel
| Article | Year |
|---|---|
Metabolism of levonorgestrel, norethindrone, and structurally related contraceptive steroids.
Topics: Animals; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
[What does the micropill bring?].
Topics: Blood Coagulation; Carbohydrate Metabolism; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipid Metabolism; Norgestrel; Norpregnenes; Ovary; Progesterone Congeners; Risk | 1986 |
Subdermal contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norprogesterones; Ovulation; Progesterone | 1995 |
Implanon. A review of clinical studies.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Dysmenorrhea; Female; Humans; Hypertension; Levonorgestrel; Research Design; Vinyl Compounds; Weight Gain | 1999 |
Insertion and removal of Implanon.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
The pharmacodynamics and efficacy of Implanon. An overview of the data.
Topics: Adolescent; Adult; Cervix Mucus; Contraceptive Agents, Female; Desogestrel; Endometrium; Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation; Progesterone; Progesterone Congeners; Radioimmunoassay; Randomized Controlled Trials as Topic; Ultrasonography; Vinyl Compounds | 1998 |
An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dysmenorrhea; Female; Hemoglobins; Humans; Levonorgestrel; Longitudinal Studies; Medical Records; Menstruation Disturbances; Patient Dropouts; Progesterone Congeners; Randomized Controlled Trials as Topic; Vinyl Compounds | 1998 |
An integrated analysis of nonmenstrual adverse events with Implanon.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Headache; Humans; Levonorgestrel; Medical Records; Pain; Patient Dropouts; Progesterone Congeners; Vinyl Compounds; Weight Gain | 1998 |
[New forms of hormonal contraception].
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Implants; Ethinyl Estradiol; Female; Humans; Intrauterine Devices; Levonorgestrel; Norpregnenes; Vinyl Compounds | 2000 |
[Contraception].
Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds | 2000 |
Risk of venous thromboembolism from oral contraceptives containing gestodene and desogestrel versus levonorgestrel: a meta-analysis and formal sensitivity analysis.
Topics: Contraceptives, Oral; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Venous Thrombosis | 2001 |
Implant contraception.
Topics: Cervix Mucus; Clinical Trials as Topic; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Female; Humans; Levonorgestrel; Megestrol; Norprogesterones; Ovulation; Patient Satisfaction; Pregnancy; Progesterone Congeners; Randomized Controlled Trials as Topic; Risk Factors; Vinyl Compounds | 2001 |
Contraceptive vaginal rings.
Topics: Administration, Intravaginal; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Estradiol; Estrogens; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Norprogesterones; Patient Acceptance of Health Care; Progesterone; Progestins; Vinyl Compounds | 2001 |
[Hormonal contraception and thromboembolic disease--pathophysiologic findings and practical recommendations].
Topics: Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Hemostasis; Humans; Levonorgestrel; Progestins; Thromboembolism | 2001 |
Bleeding problems and progestogen-only contraception.
Topics: Administration, Oral; Contraceptive Agents, Female; Counseling; Desogestrel; Drug Implants; Endometrium; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Menstruation Disturbances; Progesterone Congeners | 2002 |
Is Cerazette the minipill of choice?
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Costs; Female; Humans; Levonorgestrel; Middle Aged; Ovulation; Randomized Controlled Trials as Topic | 2003 |
Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception.
Topics: Adult; Clinical Trials as Topic; Contraception; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Female; Follow-Up Studies; Humans; Italy; Levonorgestrel; Middle Aged; Multicenter Studies as Topic; Pregnancy; Pregnancy Rate; Progesterone Congeners | 2003 |
Use of progestins in male contraception.
Topics: Asian People; Contraception; Cyproterone Acetate; Desogestrel; Humans; Levonorgestrel; Male; Medroxyprogesterone; Nandrolone; Progestins; Steroids; Testosterone; Time Factors; White People | 2003 |
Nondaily hormonal contraception: establishing a fit between product characteristics and patient preferences.
Topics: Affect; Contraception; Contraception Behavior; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Drug Combinations; Drug Implants; Ethisterone; Female; Humans; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norgestrel; Oximes; Patient Education as Topic; Progesterone Congeners; Risk Factors; United States; Weight Gain; Women's Health | 2004 |
Advances in female hormonal contraception: current alternatives to oral regimens.
Topics: Contraceptive Agents, Female; Desogestrel; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone | 2003 |
Male contraception: expanding reproductive choice.
Topics: Androgens; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Cyproterone; Desogestrel; Dihydrotestosterone; Epitopes; Estrogens; Hormones; Humans; Levonorgestrel; Male; Nandrolone; Spermatogenesis; Spermatozoa; Testosterone; Time Factors | 2005 |
Hormonal contraception: recent advances.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Combinations; Ethisterone; Female; Humans; Levonorgestrel; Male; Medroxyprogesterone Acetate; Norgestrel; Oximes; Venous Thrombosis; Women's Health | 2006 |
Alternatives to oral regimens of contraception.
Topics: Administration, Cutaneous; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral; Desogestrel; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Levonorgestrel; Male; Progestins; Sterilization, Tubal; Treatment Outcome; Vasectomy | 2007 |
Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Menstruation; Randomized Controlled Trials as Topic | 2007 |
Impact of combined and progestogen-only contraceptives on bone mineral density.
Topics: Bone Density; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Therapy, Combination; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menarche; Osteoporosis; Progesterone | 2009 |
Helping women choose appropriate hormonal contraception: update on risks, benefits, and indications.
Topics: Adult; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Counseling; Desogestrel; Evidence-Based Medicine; Family Planning Services; Family Practice; Female; Humans; Injections, Intramuscular; Injections, Subcutaneous; Levonorgestrel; Medroxyprogesterone Acetate; Ovulation Inhibition; Practice Guidelines as Topic; Pregnancy; Risk Factors; Women's Health; World Health Organization | 2009 |
Risk of venous thromboembolism among users of oral contraceptives: a review of two recently published studies.
Topics: Bias; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Denmark; Desogestrel; Estrogens; Female; Humans; Levonorgestrel; Netherlands; Progesterone; Progestins; Risk Factors; Time Factors; Venous Thromboembolism | 2010 |
Progestin-only pills for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Progestins; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2010 |
Considerations for the use of progestin-only contraceptives.
Topics: Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Contraceptives, Postcoital; Counseling; Desogestrel; Drug Prescriptions; Family Planning Services; Female; Health Promotion; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Patient Education as Topic; Patient Selection; Pregnancy, Unplanned; Progesterone Congeners; Risk Factors; United States | 2010 |
Steroid hormones for contraception in men.
Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone | 2012 |
The effects of hormonal contraceptives on female sexuality: a review.
Topics: Acne Vulgaris; Cervix Mucus; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; History, 20th Century; Humans; Levonorgestrel; Libido; Medroxyprogesterone Acetate; Progesterone Congeners; Sex Hormone-Binding Globulin; Sexuality; Vulva; Vulvodynia | 2012 |
Immediate post-partum initiation of intrauterine contraception and implants: a review of the safety and guidelines for use.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Levonorgestrel; Postpartum Period; Practice Guidelines as Topic; Pregnancy | 2013 |
Long-acting reversible contraception: a review in special populations.
Topics: Age Factors; Animals; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; HIV Infections; Humans; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Risk Factors; Sexually Transmitted Diseases | 2014 |
Progestin-only pills for contraception.
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Progestins; Randomized Controlled Trials as Topic; Uterine Hemorrhage | 2013 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
Male contraception.
Topics: Adamantane; Administration, Cutaneous; Androgens; Animals; Antispermatogenic Agents; Azoospermia; Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Estrenes; Evidence-Based Medicine; Gels; Humans; Injections, Intramuscular; Levonorgestrel; Male; Oligospermia; Progestins; Sperm Count; Testosterone; Vasectomy | 2014 |
Plan A: postabortion contraception.
Topics: Abortion, Induced; Aftercare; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Counseling; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Sterilization, Tubal | 2014 |
Postpartum contraception.
Topics: Amenorrhea; Birth Intervals; Breast Feeding; Condoms; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone Acetate; Postpartum Period; Sterilization, Tubal; Venous Thromboembolism | 2014 |
Increasing LARC utilization: any woman, any place, any time.
Topics: Attitude of Health Personnel; Contraceptive Agents, Female; Desogestrel; Drug Implants; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progestins | 2014 |
Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.
Topics: Breast Feeding; Child Development; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Infant; Lactation; Levonorgestrel; Milk, Human; Progestins; Randomized Controlled Trials as Topic | 2015 |
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins | 2015 |
[Development possibilities of hormone-containing implants for gynecological applications: A review].
Topics: Animals; Contraceptive Agents, Female; Desogestrel; Estradiol; Female; Humans; Infusion Pumps, Implantable; Levonorgestrel; Norprogesterones | 2015 |
Pharmacologic treatment of the ovarian endometrioma.
Topics: Contraceptives, Oral; Desogestrel; Endometriosis; Female; Humans; Levonorgestrel | 2016 |
The safety of intrauterine devices among young women: a systematic review.
Topics: Adolescent; Contraception; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pregnancy; Pregnancy, Unplanned; Randomized Controlled Trials as Topic; Risk Assessment; Young Adult | 2017 |
[Contraception for young women with focus on long-acting, reversible contraceptives].
Topics: Adolescent; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Injections, Intramuscular; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Young Adult | 2017 |
Delivery of progestins via the subdermal versus the intrauterine route: comparison of the pharmacology and clinical outcomes.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Pregnancy; Progestins | 2018 |
Systematic review of efficacy with extending contraceptive implant duration.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Progestins; Prospective Studies; Randomized Controlled Trials as Topic; Time Factors | 2019 |
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
Topics: Adult; Antineoplastic Agents, Hormonal; Bias; Contraceptives, Oral; Desogestrel; Female; Goserelin; Humans; Intrauterine Devices, Medicated; Leiomyoma; Leuprolide; Levonorgestrel; Lynestrenol; Medroxyprogesterone Acetate; Menstruation; Middle Aged; Nandrolone; Norethindrone Acetate; Premenopause; Progestins; Randomized Controlled Trials as Topic; Tumor Burden; Uterine Neoplasms | 2020 |
98 trial(s) available for levonorgestrel and desogestrel
| Article | Year |
|---|---|
Oral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparations.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Premenstrual Syndrome | 1992 |
Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
Topics: Adolescent; Adult; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipase; Lipoproteins; Liver; Norpregnenes; Progesterone Congeners; Sex Hormone-Binding Globulin; Triglycerides | 1992 |
A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
Topics: Adult; Apolipoproteins; Blood Glucose; Ceruloplasmin; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Pancuronium; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 1992 |
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation | 1991 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
The effect of follicular growth and luteal function of "missing the pill". A comparison between a monophasic and a triphasic combined oral contraceptive.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Corpus Luteum; Desogestrel; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Follicular Phase; Humans; Levonorgestrel; Luteal Phase; Norgestrel; Norpregnenes; Ovarian Follicle; Ovary; Time Factors | 1991 |
Serum lipids in Chinese patients using oral contraceptive pills.
Topics: Adult; China; Cholesterol; Congresses as Topic; Contraceptives, Oral; Desogestrel; Family Planning Services; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes | 1990 |
Low-dose oral contraceptives lower plasma levels of apolipoprotein E.
Topics: Adolescent; Adult; Apolipoproteins A; Apolipoproteins B; Apolipoproteins E; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Norgestrel; Norpregnenes; Triglycerides | 1990 |
Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Desogestrel; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Hydrocortisone; Levonorgestrel; Luteinizing Hormone; Male; Norgestrel; Norpregnenes; Pituitary Gland; Prolactin; Sex Hormone-Binding Globulin; Testosterone | 1986 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
Blood coagulation with a combination pill containing gestodene and ethinyl estradiol.
Topics: Adolescent; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism | 1987 |
A randomized cross-over comparison of two low-dose oral contraceptives upon hormonal and metabolic parameters: I. Effects upon sexual hormone levels.
Topics: Adult; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Random Allocation; Testosterone | 1985 |
A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
Topics: Adult; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phospholipids; Random Allocation; Triglycerides | 1985 |
Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1986 |
Effects of three low-dose oral contraceptive formulations on lipid metabolism.
Topics: Adolescent; Adult; Arteriosclerosis; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation | 1987 |
Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Topics: Adult; Apolipoproteins; Cholesterol, HDL; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies | 1988 |
Comparative metabolic effects of oral contraceptive preparations containing different progestagens. Effects of desogestrel + ethinylestradiol on the haemostatic balance.
Topics: Adult; Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Cholesterol; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation; Time Factors; Triglycerides | 1985 |
Effects of two progestins with different androgenic properties on hepatic endothelial lipase and high density lipoprotein2.
Topics: Androgens; Apolipoprotein A-I; Apolipoproteins A; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Endothelium; Esterification; Female; Heparin; Humans; Levonorgestrel; Lipase; Lipoproteins; Lipoproteins, HDL; Liver; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin; Testosterone | 1985 |
Serum lipid and lipoprotein changes induced by new oral contraceptives containing ethinylestradiol plus levonorgestrel or desogestrel.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Phospholipids; Triglycerides | 1985 |
Effects of desogestrel, levonorgestrel and lynestrenol on serum sex hormone binding globulin, cortisol binding globulin, ceruloplasmin and HDL-cholesterol.
Topics: Adolescent; Adult; Carrier Proteins; Ceruloplasmin; Cholesterol, HDL; Clinical Trials as Topic; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lynestrenol; Norgestrel; Norpregnenes; Random Allocation; Sex Hormone-Binding Globulin | 1985 |
Progestagens and high-density lipoproteins.
Topics: Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1984 |
Effects of desogestrel and levonorgestrel in low-dose oestrogen oral contraceptives on serum lipoproteins.
Topics: Adult; Cholesterol; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes | 1982 |
Comparative effects of the oral contraceptive combinations 0.150 mg desogestrel + 0.030 mg ethinyloestradiol and 0.150 mg levonorgestrel + 0.030 mg ethinyloestradiol on lipid and lipoprotein metabolism in healthy female volunteers.
Topics: Adolescent; Adult; Body Weight; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Norgestrel; Norpregnenes; Phosphatidylcholines; Triglycerides | 1982 |
Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
Topics: Adolescent; Adult; Blood Proteins; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Denmark; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Norway; Pregnancy; Sex Hormone-Binding Globulin; Sweden; Transcortin | 1982 |
Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins A; Apolipoproteins B; Cholesterol, HDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glycoproteins; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL; Norgestrel; Norpregnenes; Progesterone Congeners; Stereoisomerism; Triglycerides | 1984 |
[Regression of functional cysts: high dosage ovulation inhibitor and gestagen therapy has no added effect].
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lynestrenol; Ovarian Cysts; Ovary; Progesterone Congeners; Prospective Studies; Remission, Spontaneous; Retrospective Studies; Treatment Outcome | 1995 |
Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
Topics: Breast; Climacteric; Desogestrel; Drug Administration Schedule; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Flushing; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Menstrual Cycle; Middle Aged; Norethindrone; Norethindrone Acetate; Progesterone Congeners | 1994 |
Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Topics: Administration, Intravaginal; Adolescent; Adult; Desogestrel; Developing Countries; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Multicenter Studies as Topic; Patient Acceptance of Health Care; Pregnancy; Random Allocation; Vagina | 1993 |
Role of cigarette smoking on the postmenopausal endometrium during sequential estrogen and progestogen therapy.
Topics: Desogestrel; Endometrium; Estradiol; Estradiol Dehydrogenases; Estrogen Replacement Therapy; Female; Glycodelin; Glycoproteins; Humans; Isocitrate Dehydrogenase; Levonorgestrel; Medroxyprogesterone Acetate; Middle Aged; Osteoporosis, Postmenopausal; Pregnancy Proteins; Smoking | 1993 |
Effect of four combined oral contraceptives on blood pressure in the pill-free interval.
Topics: Adolescent; Adult; Blood Pressure; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; Levonorgestrel; Norethindrone; Norpregnenes; Prospective Studies; Time Factors | 1993 |
The effects of two phasic oral contraceptives on hemostasis and platelet function.
Topics: Blood Coagulation; Blood Coagulation Factors; Blood Platelets; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinolysis; Hemostasis; Humans; Levonorgestrel | 1995 |
Ovarian activity suppression by two different low-dose triphasic oral contraceptives.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Progesterone Congeners; Ultrasonography | 1995 |
Impact of combined hormone replacement therapy on serum lipid metabolism: new aspects.
Topics: Apolipoproteins B; Cholesterol, LDL; Denmark; Desogestrel; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipoproteins, LDL; Medroxyprogesterone Acetate; Middle Aged; Particle Size; Placebos; Prospective Studies | 1997 |
Immature spermatids are not prevalent in semen from men who are receiving androgen-based contraceptive regimens.
Topics: Adult; Androgens; Cellular Senescence; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Humans; Levonorgestrel; Male; Middle Aged; Semen; Sperm Count; Spermatids; Testosterone | 1998 |
Ovarian function during the use of a single contraceptive implant: Implanon compared with Norplant.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrium; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Ovarian Follicle; Progesterone; Progesterone Congeners; Prospective Studies; Sex Hormone-Binding Globulin; Time Factors; Vinyl Compounds | 1998 |
A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgram levonorgestrel.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Factor VII; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Progesterone Congeners; Protein S; Prothrombin | 1998 |
Effects on the hemostatic system and liver function in relation to Implanon and Norplant. A prospective randomized clinical trial.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Female; Hemostasis; Humans; Levonorgestrel; Liver; Liver Function Tests; Progesterone Congeners; Prospective Studies; Vinyl Compounds | 1998 |
A 2-year comparative study of endometrial histology and cervical cytology of contraceptive implant users in Birmingham, UK.
Topics: Adolescent; Adult; Cervix Uteri; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometrial Neoplasms; Endometrium; Female; Humans; Hyperplasia; Levonorgestrel; Prospective Studies; Risk Factors; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Vaginal Smears; Vinyl Compounds | 1998 |
Twenty-four month comparison of apolipoproteins A-1, A-II and B in contraceptive implant users (Norplant and Implanon) in Birmingham, United Kingdom.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Contraceptive Agents, Female; Coronary Disease; Desogestrel; Drug Implants; Educational Status; Female; Humans; Levonorgestrel; Risk Factors; Socioeconomic Factors; United Kingdom; Vinyl Compounds | 1998 |
A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progest
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Female; Humans; Levonorgestrel; Menstruation Disturbances; Middle Aged; Patient Satisfaction; Pregnancy; Progesterone Congeners; Safety; Time Factors | 1998 |
A comparison of the inhibition of ovulation achieved by desogestrel 75 micrograms and levonorgestrel 30 micrograms daily.
Topics: Administration, Oral; Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Ovulation; Treatment Outcome | 1999 |
Comparison of the effects of triphasic oral contraceptives with desogestrel or levonorgestrel on apolipoprotein A-I-containing high-density lipoprotein particles.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Contraceptives, Oral, Sequential; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipids; Lipoproteins, HDL | 1999 |
An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
Topics: Blood Coagulation; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemostasis; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Peptide Fragments; Prothrombin; Thrombin; Venous Thrombosis | 1999 |
A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; China; Contraceptive Agents, Female; Desogestrel; Female; Hemoglobins; Humans; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Uterine Hemorrhage; Vinyl Compounds | 1999 |
Low-dose oral contraceptives and acquired resistance to activated protein C: a randomised cross-over study.
Topics: Activated Protein C Resistance; Adolescent; Adult; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein C; Risk Factors; Thrombin; Thromboembolism | 1999 |
The effects of Implanon on lipid metabolism in comparison with Norplant.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Indonesia; Intrauterine Devices; Levonorgestrel; Lipids; Time Factors; Vinyl Compounds | 1999 |
Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
Topics: Adolescent; Adult; Antithrombin III; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Humans; Levonorgestrel; Peptide Fragments; Peptide Hydrolases; Prothrombin; Risk Factors; Thrombin; Thrombophilia; Venous Thrombosis | 2000 |
Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
Topics: Adolescent; Adult; alpha-2-Antiplasmin; Biomarkers; Blood Proteins; Carboxypeptidase B2; Carboxypeptidases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Factor XI; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Fibrinolysis; Humans; Levonorgestrel; Netherlands; Peptide Fragments; Plasminogen; Plasminogen Activator Inhibitor 1; Prothrombin; Thrombophilia; Tissue Plasminogen Activator | 2000 |
A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways.
Topics: Activated Protein C Resistance; Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombins; Biomarkers; Blood Coagulation; Blood Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Netherlands; Partial Thromboplastin Time; Protein C; Protein C Inhibitor; Protein S; Thrombin; Thrombophilia | 2000 |
Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and high-density lipoprotein suppression.
Topics: Acne Vulgaris; Adult; Blood Chemical Analysis; Cholesterol; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Gynecomastia; Humans; Levonorgestrel; Lipoproteins, HDL; Male; Middle Aged; Oligospermia; Sperm Count; Spermatogenesis; Testosterone; Weight Gain | 2000 |
Effect of Implanon use on selected parameters of thyroid and adrenal function.
Topics: Adrenal Cortex; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Hydrocortisone; Levonorgestrel; Longitudinal Studies; Random Allocation; Sex Hormone-Binding Globulin; Thyroid Gland; Thyroid Hormones; Time Factors; Vinyl Compounds | 2000 |
Changes in blood coagulation and fibrinolysis associated with maximal exercise and physical conditioning in women taking low dose oral contraceptives.
Topics: Adult; Analysis of Variance; Blood Coagulation; Conditioning, Psychological; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Exercise Test; Female; Fibrinolysis; Humans; Levonorgestrel; Physical Education and Training; Physical Exertion; Probability; Reference Values; Thrombophilia | 2000 |
Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Apolipoprotein A-I; Apolipoprotein A-II; Apolipoproteins B; Blood Coagulation; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Female; Fibrinolysis; Hemostasis; Humans; Insulin; Levonorgestrel; Lipids; Lipoprotein(a); Sex Hormone-Binding Globulin; Triglycerides | 2001 |
Implanon contraceptive implants: effects on carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; Contraceptive Agents, Female; Desogestrel; Drug Implants; Fasting; Female; Glucose Tolerance Test; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Kinetics; Levonorgestrel; Vinyl Compounds | 2001 |
The effects of two progrestogen-only pills containing either desogestrel (75 microgram/day) or levonorgestrel (30 microgram/day) on carbohydrate metabolism and adrenal and thyroid function.
Topics: Adolescent; Adrenal Glands; Adult; Carbohydrate Metabolism; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Female; Finland; Humans; Levonorgestrel; Middle Aged; Pregnancy; Reference Values; Thyroid Gland | 2001 |
Effects of two low-dose oral contraceptives containing ethinylestradiol and either desogestrel or levonorgestrel on serum lipids and lipoproteins with particular regard to LDL size.
Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins | 2001 |
The effects of two progestogen-only pills containing either desogestrel (75 microg/day) or levonorgestrel (30 microg/day) on lipid metabolism.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Middle Aged; Treatment Outcome | 2001 |
Different effects of oral contraceptives containing levonorgestrel or desogestrel on plasma lipoproteins and coagulation factor VII.
Topics: Adult; Cholesterol, HDL; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cross-Over Studies; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Factor VII; Factor VIIa; Female; Humans; Levonorgestrel; Lipoproteins; Peptide Fragments; Prospective Studies; Prothrombin; Triglycerides | 2002 |
Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor IX; Factor V; Factor VII; Female; Humans; Levonorgestrel; Peptide Fragments; Prothrombin; Thrombophilia | 2002 |
Effect of second and third generation oral contraceptives on lipid metabolism in the absence or presence of the factor V Leiden mutation.
Topics: Adolescent; Adult; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins, HDL; Point Mutation; Progesterone Congeners; Triglycerides | 2001 |
Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
Topics: Activated Protein C Resistance; Adult; Carboxypeptidase B2; Contraceptives, Oral, Hormonal; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Factor V; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Humans; Levonorgestrel; Thrombophilia | 2002 |
Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism.
Topics: Adolescent; Adult; Androgens; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Middle Aged; Severity of Illness Index; Sex Hormone-Binding Globulin; Treatment Outcome | 2003 |
A randomized controlled trial of second- versus third-generation oral contraceptives in the treatment of acne vulgaris.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral; Dehydroepiandrosterone Sulfate; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome | 2003 |
[A randomized study comparing the efficacy and bleeding pattern of Implanon and Norplant hormonal contraceptive implant].
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Uterine Hemorrhage | 2003 |
Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation.
Topics: Adult; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Bupropion; Contraceptives, Oral; Cross-Over Studies; Cytochrome P-450 CYP2B6; Desogestrel; Dopamine Uptake Inhibitors; Estradiol; Ethinyl Estradiol; Female; Half-Life; Hormone Replacement Therapy; Humans; Hydroxylation; Levonorgestrel; Metabolic Clearance Rate; Oxidoreductases, N-Demethylating | 2003 |
Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Mutation; Protein C; Risk Factors; Thrombosis | 2004 |
Effect of Implanon and Norplant subdermal contraceptive implants on serum lipids--a randomized comparative study.
Topics: Adolescent; Adult; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Desogestrel; Drug Implants; Humans; Levonorgestrel; Lipids; Triglycerides | 2003 |
The combined contraceptive vaginal ring (NuvaRing) and lipid metabolism: a comparative study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Apolipoproteins; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Triglycerides | 2004 |
Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.
Topics: Adult; Body Mass Index; Contraceptives, Oral, Combined; Desogestrel; Double-Blind Method; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle; Ovarian Follicle | 2004 |
Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol.
Topics: Acne Vulgaris; Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Germany; Humans; Levonorgestrel; Menstrual Cycle; Middle Aged; Netherlands; Premenstrual Syndrome; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 2004 |
Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Ovarian Follicle; Treatment Outcome; Ultrasonography | 2004 |
Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests -- a randomized comparative study with Norplant implants.
Topics: Adult; Bilirubin; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Liver; Liver Function Tests; Progesterone Congeners; Treatment Outcome | 2004 |
Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide.
Topics: Activated Protein C Resistance; Chromatography, High Pressure Liquid; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Glucosylceramides; Humans; Levonorgestrel; Pilot Projects; Protein C; Protein S; Prothrombin Time; Risk; Sensitivity and Specificity; Venous Thrombosis | 2005 |
A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants.
Topics: Absorptiometry, Photon; Adult; Bone Density; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Radius; Ulna | 2006 |
Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives.
Topics: Administration, Intravaginal; Adult; Affect; Contraceptive Agents, Female; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Libido; Menstrual Cycle; Norpregnenes; Prospective Studies; Reproduction; Uterine Hemorrhage | 2006 |
Comparison of the skeletal effects of the progestogens desogestrel and levonorgestrel in oral contraceptive preparations in young women: controlled, open, partly randomized investigation over 13 cycles.
Topics: Absorptiometry, Photon; Adolescent; Adult; Alkaline Phosphatase; Bone and Bones; Bone Density; Collagen Type I; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Lumbar Vertebrae; Osteocalcin; Peptides; Radius; Tibia; Tomography, X-Ray Computed | 2006 |
Comparison of a transdermal contraceptive patch vs. oral contraceptives on hemostasis variables.
Topics: Administration, Cutaneous; Administration, Oral; Adolescent; Adult; Antifibrinolytic Agents; Biomarkers; Blood Coagulation; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Fibrinolysin; Homeostasis; Humans; Levonorgestrel; Middle Aged; Peptide Fragments; Prospective Studies; Protein Precursors; Prothrombin | 2008 |
Oral contraceptives elevate core temperature and heart rate during exercise in the heat.
Topics: Adult; Body Temperature; Body Temperature Regulation; Contraceptives, Oral; Desogestrel; Drug Combinations; Drug Therapy, Combination; Ethinyl Estradiol; Exercise; Female; Heart Rate; Hot Temperature; Humans; Levonorgestrel; Luteal Phase; Mestranol; Norethindrone; Norgestrel; Skin Temperature | 1997 |
An open-label, comparative study of the effects of a dose-reduced oral contraceptive containing 0.02 mg ethinylestradiol/2 mg chlormadinone acetate on hemostatic parameters and lipid and carbohydrate metabolism variables.
Topics: Adolescent; Adult; Carbohydrate Metabolism; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Hemostasis; Humans; Levonorgestrel; Lipid Metabolism; Young Adult | 2010 |
Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Hirsutism; Humans; Levonorgestrel; Weight Gain; Young Adult | 2011 |
The APC-PCI concentration as an early marker of activation of blood coagulation: a study of women on combined oral contraceptives.
Topics: Adult; Antithrombin III; Blood Coagulation; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Peptide Hydrolases; Protein C; Protein C Inhibitor; Thrombophilia; Young Adult | 2012 |
A multicenter randomized clinical trial of one-rod etonogestrel and two-rod levonorgestrel contraceptive implants with nonrandomized copper-IUD controls: methodology and insertion data.
Topics: Adult; Chi-Square Distribution; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Levonorgestrel; Pain; Pruritus; Time Factors; Young Adult | 2013 |
Effect of hormonal contraceptives during breastfeeding on infant's milk ingestion and growth.
Topics: Adolescent; Adult; Breast Feeding; Child Development; Contraceptives, Oral, Combined; Desogestrel; Eating; Female; Humans; Infant; Infant Nutritional Physiological Phenomena; Intrauterine Devices, Copper; Levonorgestrel; Male; Milk, Human; Progestins; Young Adult | 2013 |
A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Topics: Adult; Body Mass Index; Contraception; Contraceptive Agents, Female; Counseling; Desogestrel; Female; Hemorrhage; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Weight Gain | 2014 |
Multinational, multicentre, randomised, open-label study evaluating the impact of a 91-day extended regimen combined oral contraceptive, compared with two 28-day traditional combined oral contraceptives, on haemostatic parameters in healthy women.
Topics: Adolescent; Adult; Blood Coagulation; Contraceptives, Oral, Combined; Delayed-Action Preparations; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Factor VII; Factor VIII; Female; Fibrin Fibrinogen Degradation Products; Humans; Levonorgestrel; Partial Thromboplastin Time; Prothrombin; Young Adult | 2014 |
Randomized comparison of bleeding patterns in women using a combined contraceptive vaginal ring or a low-dose combined oral contraceptive on a menstrually signaled regimen.
Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Drug Combinations; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; New South Wales; Patient Education as Topic; Patient Satisfaction; Self Care; Young Adult | 2015 |
Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Ovary; Ovulation Inhibition; Progesterone; Ultrasonography | 2015 |
A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Outcome Assessment, Health Care; Pregnancy; Pregnancy, Unplanned; Time Factors; Young Adult | 2015 |
A 12-month multicenter, randomized study comparing the levonorgestrel intrauterine system with the etonogestrel subdermal implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Europe; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Menstruation; Patient Satisfaction; Pregnancy; Pregnancy, Unplanned; Time Factors; Treatment Outcome; Young Adult | 2016 |
Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding.
Topics: Adult; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Incidence; India; Levonorgestrel; Medication Adherence; Menorrhagia; Menstrual Cycle; Metrorrhagia; Patient Acceptance of Health Care; Severity of Illness Index | 2016 |
Extended use up to 5 years of the etonogestrel-releasing subdermal contraceptive implant: comparison to levonorgestrel-releasing subdermal implant.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Family Planning Services; Female; Humans; Levonorgestrel; Treatment Outcome; Young Adult | 2016 |
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial.
Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult | 2016 |
A multicenter randomized clinical trial of etonogestrel and levonorgestrel contraceptive implants with nonrandomized copper intrauterine device controls: effect on weight variations up to 3 years after placement.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Weight Gain; Young Adult | 2018 |
Assessment of biomarkers in women with endometriosis-associated pain using the ENG contraceptive implant or the 52 mg LNG-IUS: a non-inferiority randomised clinical trial.
Topics: Adult; Biomarkers; Brazil; CA-125 Antigen; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Endometrium; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Nerve Fibers; Pelvic Pain; Receptors, IgE; Treatment Outcome | 2018 |
Control of endometriosis-associated pain with etonogestrel-releasing contraceptive implant and 52-mg levonorgestrel-releasing intrauterine system: randomized clinical trial.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Liberation; Endometriosis; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pain Management; Pelvic Pain | 2018 |
Pragmatic cluster randomised cohort cross-over trial to determine the effectiveness of bridging from emergency to regular contraception: the Bridge-It study protocol.
Topics: Abortion, Induced; Adult; Contraception Behavior; Contraception, Postcoital; Contraceptive Agents, Female; Cross-Over Studies; Desogestrel; Female; Humans; Levonorgestrel; Pharmacy; Pilot Projects; Pragmatic Clinical Trials as Topic; Pregnancy; Pregnancy, Unplanned; Progestins; Surveys and Questionnaires; Young Adult | 2019 |
Endometriosis-associated pain scores and biomarkers in users of the etonogestrel-releasing subdermal implant or the 52-mg levonorgestrel-releasing intrauterine system for up to 24 months.
Topics: Adolescent; Adult; Brazil; CA-125 Antigen; Desogestrel; Drug Implants; Dysmenorrhea; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pain Measurement; Pelvic Pain; Young Adult | 2020 |
Can a 3 months treatment with oral Desogestrel prior to insertion of the etonogestrel-releasing contraceptive implant improve continuation rate at 1 year? A randomized trial.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Time Factors | 2023 |
169 other study(ies) available for levonorgestrel and desogestrel
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
Insulin resistance, secretion, and metabolism in users of oral contraceptives.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Contraceptives, Oral; Desogestrel; Female; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Insulin Secretion; Levonorgestrel; Middle Aged; Norethindrone; Norpregnenes | 1992 |
Effects of low-dose oral contraceptives on female whole saliva.
Topics: Adult; Buffers; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Male; Menstrual Cycle; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone Congeners; Saliva; Salivary Proteins and Peptides | 1991 |
Clinical results with subcutaneous implants containing 3-keto desogestrel.
Topics: Binding, Competitive; Contraceptives, Oral, Combined; Desogestrel; Dihydrotestosterone; Drug Implants; Estradiol; Female; Humans; Levonorgestrel; Menstruation; Norgestrel; Norpregnenes; Ovulation; Progesterone; Progesterone Congeners; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Relative binding affinity of norgestimate and other progestins for human sex hormone-binding globulin.
Topics: Binding, Competitive; Desogestrel; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progestins; Sex Hormone-Binding Globulin; Testosterone | 1990 |
Potency and pharmacokinetics of gestagens.
Topics: Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes | 1990 |
Effects of three combined oral contraceptive preparations containing desogestrel plus ethinyl estradiol on lipid metabolism in comparison with two levonorgestrel preparations.
Topics: Adult; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Norgestrel; Norpregnenes; Progesterone Congeners | 1990 |
The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.
Topics: Adolescent; Adult; Blood Glucose; C-Peptide; Carbohydrate Metabolism; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Ethynodiol Diacetate; Female; Humans; Insulin; Levonorgestrel; Lipid Metabolism; Middle Aged; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Triglycerides | 1990 |
Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin.
Topics: Administration, Oral; Adult; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Half-Life; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Radioimmunoassay; Sex Hormone-Binding Globulin | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Altered growth hormone secretion during oral contraception.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Growth Hormone; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pituitary Gland, Anterior; Progesterone Congeners | 1990 |
Binding of oral contraceptive progestogens to serum proteins and cytoplasmic receptor.
Topics: Animals; Binding, Competitive; Blood Proteins; Contraceptives, Oral, Hormonal; Cytoplasm; Desogestrel; Female; Humans; Kinetics; Levonorgestrel; Male; Norgestrel; Norpregnenes; Pregnancy; Progesterone; Progesterone Congeners; Progestins; Rats; Rats, Inbred Strains; Receptors, Cell Surface; Sex Hormone-Binding Globulin; Transcortin; Uterus | 1990 |
Binding of levonorgestrel, norethisterone and desogestrel to human sex hormone binding globulin and influence on free testosterone levels.
Topics: Binding, Competitive; Desogestrel; Female; Humans; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnancy; Pregnancy Trimester, Third; Sex Hormone-Binding Globulin; Testosterone | 1989 |
Endometrial morphology during a normophasic and a triphasic regimen: a comparison.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Sequential; Desogestrel; Endometrium; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes | 1986 |
Postponement of withdrawal bleeding in women using low-dose combined oral contraceptives.
Topics: Adult; Amenorrhea; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Life Style; Menstrual Cycle; Norgestrel; Norpregnenes | 1987 |
Progestins and oral contraceptive-induced lipoprotein changes: a prospective study.
Topics: Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norethindrone; Norgestrel; Norpregnenes; Population Surveillance; Progesterone Congeners; Prospective Studies; Risk | 1987 |
Coagulation effects of oral contraception.
Topics: Blood Coagulation; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinolysis; Humans; Levonorgestrel; Mestranol; Norethindrone; Norethindrone Acetate; Norgestrel; Norpregnenes; Platelet Aggregation; Risk Factors; Thromboembolism; Thrombosis | 1987 |
New progestogens in oral contraceptives.
Topics: Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Glucose; Glucose Tolerance Test; Humans; Insulin; Levonorgestrel; Lipids; Lipoproteins; Norgestrel; Norpregnenes; Progesterone Congeners | 1987 |
Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cholesterol, HDL; Contraceptives, Oral; Desogestrel; Epoprostenol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norgestrel; Norpregnenes; Thromboxane A2; Thromboxane B2 | 1987 |
Trace elements during 2 years' oral contraception with low-estrogen preparations.
Topics: Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Copper; Desogestrel; Ethinyl Estradiol; Female; Humans; Iron; Levonorgestrel; Norgestrel; Norpregnenes; Trace Elements; Zinc | 1988 |
Progestagen-dependent effect on some plasma proteins during oral contraception.
Topics: Blood Proteins; Ceruloplasmin; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Pregnancy Proteins; Progesterone Congeners; Sex Hormone-Binding Globulin; Transcortin | 1988 |
Comparative effects of combined oral contraceptives containing desogestrel or levonorgestrel on serum lipids, lipoproteins and sex hormone binding globulin in healthy women.
Topics: Adult; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Lipoproteins; Norgestrel; Norpregnenes; Prospective Studies; Random Allocation; Sex Hormone-Binding Globulin; Triglycerides | 1988 |
Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel.
Topics: Adolescent; Adult; Androstenedione; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Desogestrel; Female; Fertility; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Saliva; Sex Hormone-Binding Globulin; Testosterone | 1988 |
Bioactive LH in women with polycystic ovaries and the effect of gonadotrophin suppression.
Topics: Adolescent; Adult; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Menstrual Cycle; Norgestrel; Norpregnenes; Polycystic Ovary Syndrome; Progesterone; Progesterone Congeners | 1988 |
Selectivity in progesterone and androgen receptor binding of progestagens used in oral contraceptives.
Topics: Cell Line; Cytosol; Desogestrel; Dihydrotestosterone; In Vitro Techniques; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Pregnenediones; Receptors, Androgen; Receptors, Progesterone; Tritium | 1988 |
The effects of two gonane progestins alone and in combination with ethinyl estradiol on serum lipoproteins.
Topics: Adult; Castration; Cholesterol; Contraceptives, Oral, Combined; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norgestrel; Norpregnenes | 1985 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
Anti-estrogenic effects of contraceptive progestins on the dynamics of gonadotropin release.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Longitudinal Studies; Luteinizing Hormone; Lynestrenol; Norgestrel; Norpregnenes; Pituitary Gland | 1982 |
Effects of two oral contraceptive combinations, 0.125 mg desogestrel + 0.050 mg ethinylestradiol and 0.125 mg levonorgestrel + 0.050 mg ethinylestradiol on the adrenal function of healthy female volunteers.
Topics: 17-Hydroxycorticosteroids; Adrenal Cortex; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Hydrocortisone; Levonorgestrel; Metyrapone; Norgestrel; Norpregnenes; Progestins; Random Allocation | 1982 |
Endocrinological studies with desogestrel.
Topics: Administration, Oral; Animals; Castration; Contraceptives, Oral, Combined; Decidua; Desogestrel; Endometrium; Estrogen Antagonists; Female; Levonorgestrel; Mice; Norethindrone; Norgestrel; Norpregnenes; Ovulation; Pregnancy; Progesterone Congeners; Rabbits; Rats; Species Specificity | 1983 |
Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Gonadotropins, Pituitary; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Norpregnenes; Progesterone; Prolactin; Random Allocation; Serum Globulins; Sex Hormone-Binding Globulin; Transcortin | 1983 |
Serum steroid binding protein concentrations, distribution of progestogens, and bioavailability of testosterone during treatment with contraceptives containing desogestrel or levonorgestrel.
Topics: Adult; Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Radioimmunoassay; Serum Albumin; Sex Hormone-Binding Globulin; Testosterone; Transcortin | 1984 |
Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Apolipoprotein A-I; Apolipoproteins; Arteriosclerosis; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Middle Aged; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1984 |
Changes in relative fatty acid composition of serum lecithin and cholesterol ester after treatment with two gonane progestins administered alone and in combination with ethinyl estradiol.
Topics: Adult; Castration; Cholesterol Esters; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fatty Acids; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Norpregnenes; Phosphatidylcholines; Progesterone Congeners; Stereoisomerism; Uterine Cervical Neoplasms | 1984 |
Effect of different progestagens in low oestrogen oral contraceptives on venous thromboembolic disease. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Age Factors; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Progestins; Risk Factors; Smoking; Thromboembolism; Time Factors | 1995 |
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism | 1995 |
Changes in blood levels of proteinase inhibitors, pregnancy zone protein, steroid carriers and complement factors induced by oral contraceptives.
Topics: Adolescent; Adult; alpha 1-Antitrypsin; alpha-Macroglobulins; Antithrombin III; Carrier Proteins; Complement System Proteins; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Norgestrel; Pregnancy Proteins; Protease Inhibitors; Serum Albumin; Sex Hormone-Binding Globulin; Steroids; Transcortin | 1993 |
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease.
Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors | 1995 |
Influence of oral contraceptive use on lipoprotein (a) and other coronary heart disease risk factors.
Topics: Adolescent; Adult; Analysis of Variance; Cohort Studies; Contraceptives, Oral; Coronary Disease; Desogestrel; Female; Humans; Levonorgestrel; Life Style; Lipoprotein(a); Lipoproteins; Radioimmunoassay; Risk Factors; Smoking | 1995 |
Contraceptive implants.
Topics: Adolescent; Adult; Consumer Behavior; Consumer Product Safety; Contraceptive Agents; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Megestrol; Menstruation Disturbances; Norpregnadienes | 1994 |
Influence of changes in the concentration of sex hormone-binding globulin in human serum on the protein binding of the contraceptive steroids levonorgestrel, 3-keto-desogestrel and gestodene.
Topics: Adult; Clinical Trials as Topic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Serum Albumin; Sex Hormone-Binding Globulin | 1994 |
The effects of levonorgestrel, desogestrel and gestodene on the pulsatile release of luteinizing hormone in oral contraceptive users.
Topics: Adult; Contraceptives, Oral, Hormonal; Desogestrel; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Levonorgestrel; Luteinizing Hormone; Norpregnenes; Periodicity | 1993 |
Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Immunoradiometric Assay; Levonorgestrel; Luteinizing Hormone; Pituitary Gland; Time Factors | 1993 |
The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation.
Topics: Capillaries; Cell Division; Cells, Cultured; Decidua; Desogestrel; Endothelium, Vascular; Estradiol; Female; Fluorescent Antibody Technique, Indirect; Gonadal Steroid Hormones; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progesterone | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: I. MCF-7 cell lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Division; Desogestrel; Estradiol; Estrogen Antagonists; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Statistical; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Tumor Cells, Cultured | 1995 |
Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells: II. T47D cell lines.
Topics: Breast Neoplasms; Carcinoma; Cell Division; Desogestrel; Dose-Response Relationship, Drug; Estradiol; Estrenes; Estrogen Antagonists; Female; Furans; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Mifepristone; Nandrolone; Norethindrone; Norpregnenes; Pregnanes; Pregnenediones; Progesterone; Promegestone; Tumor Cells, Cultured | 1995 |
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires | 1995 |
Risk of acute myocardial infarction and low-dose combined oral contraceptives.
Topics: Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Myocardial Infarction; Norpregnenes; Progesterone Congeners; Risk; Smoking | 1996 |
Utilization patterns of oral contraceptives in UK general practice.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Family Practice; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; United Kingdom | 1996 |
Effects of oral contraceptives on plasma neutral amino acids and cholesterol during a menstrual cycle.
Topics: Adult; Amino Acids; Cholesterol; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Sequential; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstrual Cycle | 1996 |
Cardiovascular risk factors in Norwegian women using oral contraceptives: results from a cardiovascular health screening 1985-88.
Topics: Adult; Blood Pressure; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Coronary Disease; Desogestrel; Estradiol; Female; Health Surveys; Humans; Levonorgestrel; Lipids; Lynestrenol; Middle Aged; Norethindrone; Norway; Progesterone Congeners; Prospective Studies; Risk Factors; Smoking; Surveys and Questionnaires | 1996 |
The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Topics: Adolescent; Adult; Bias; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors; Thromboembolism | 1996 |
Effect of 17 alpha-ethinylestradiol, levonorgestrel, 3-keto-desogestrel, and gestodene on calcium influx via voltage-gated calcium channels in human aortic smooth muscles.
Topics: Aorta; Calcium; Calcium Channels; Calcium Radioisotopes; Cells, Cultured; Desogestrel; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel; Muscle, Smooth, Vascular; Norpregnenes; Progesterone Congeners | 1996 |
Oral contraception and venous thromboembolism. A New Zealand perspective.
Topics: Bias; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; New Zealand; Odds Ratio; Risk Factors; Thromboembolism | 1997 |
The influence of thrombotic risk factors when oral contraceptives are prescribed. A control-only study.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Causality; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Migraine Disorders; Multivariate Analysis; Norgestrel; Norpregnenes; Risk Factors; Smoking; Socioeconomic Factors; Thromboembolism | 1997 |
Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Incidence; Levonorgestrel; Myocardial Infarction; Norethindrone; Norgestrel; Risk Factors; Thrombophlebitis; United States | 1997 |
Bias in studies of venous thromboembolism in relation to the use of new formulations of oral contraceptives.
Topics: Adolescent; Adult; Age Factors; Bias; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Research Design; Thrombophlebitis | 1997 |
Risk of oral contraceptives and recency of market introduction.
Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Odds Ratio; Time Factors | 1997 |
Oral contraceptives and venous thrombosis: different sensitivities to activated protein C in women using second- and third-generation oral contraceptives.
Topics: Adolescent; Adult; Aged; Contraceptives, Oral, Combined; Desogestrel; Factor V; Female; Hemostasis; Heterozygote; Humans; Levonorgestrel; Male; Middle Aged; Norgestrel; Norpregnenes; Protein C; Thrombin; Thrombophlebitis | 1997 |
The effect of oral contraceptive agents on the basal metabolic rate of young women.
Topics: Adult; Anthropometry; Basal Metabolism; Blood Pressure; Body Composition; Calorimetry, Indirect; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Pulse; Stimulation, Chemical; Systole | 1997 |
Marked gender differences in ambulatory morning growth hormone values in young adults.
Topics: Adult; Contraceptives, Oral, Synthetic; Desogestrel; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Fasting; Female; Human Growth Hormone; Humans; Levonorgestrel; Male; Prospective Studies; Sex Factors | 1998 |
Effect of oral contraceptive progestins on serum copper concentration.
Topics: Adolescent; Adult; Androgen Antagonists; Cardiovascular Diseases; Contraceptives, Oral; Copper; Cross-Sectional Studies; Desogestrel; Female; Humans; Levonorgestrel; Norethindrone; Progesterone Congeners; Progestins; Surveys and Questionnaires | 1998 |
Risk of venous thromboembolism with third-generation oral contraceptives: A review.
Topics: Clinical Trials as Topic; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Risk Factors; Thromboembolism; Venous Thrombosis | 1999 |
Venous thromboembolic disease and combined oral contraceptives: A re-analysis of the MediPlus database.
Topics: Adolescent; Adult; Body Mass Index; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Odds Ratio; Risk Factors; Smoking; United Kingdom; Venous Thrombosis | 1999 |
Effect on stroke of different progestagens in low oestrogen dose oral contraceptives. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Topics: Adult; Case-Control Studies; Cerebrovascular Disorders; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Progesterone Congeners; Risk Factors | 1999 |
Risk of idiopathic cerebral haemorrhage in women on oral contraceptives with differing progestagen components.
Topics: Adult; Cerebral Hemorrhage; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Middle Aged; Norpregnenes; Progesterone Congeners; Risk Factors | 1999 |
Recurrent use of newer oral contraceptives and the risk of venous thromboembolism.
Topics: Adult; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Logistic Models; Norgestrel; Norpregnenes; Risk Factors; Venous Thrombosis | 2000 |
Development of contraceptive implants.
Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Evaluation; Drug Implants; Humans; Levonorgestrel; United Kingdom; Vinyl Compounds | 2000 |
[Third-generation pill].
Topics: Adult; Contraception; Contraceptives, Oral, Synthetic; Contraindications; Counseling; Desogestrel; Female; Humans; Levonorgestrel; Netherlands; Risk Assessment; Secondary Prevention; Thrombophlebitis | 2000 |
Renewed interest in haemostasis changes induced by oral contraceptives (OCs)
Topics: Activated Protein C Resistance; Adult; Biomarkers; Blood Coagulation Factors; Blood Proteins; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Over Studies; Desogestrel; Ethinyl Estradiol; Female; Genetic Predisposition to Disease; Hemostasis; Humans; Levonorgestrel; Partial Thromboplastin Time; Randomized Controlled Trials as Topic; Thrombophilia; Venous Thrombosis | 2000 |
The progestin levonorgestrel induces endothelium-independent relaxation of rabbit jugular vein via inhibition of calcium entry and protein kinase C: role of cyclic AMP.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Calcium; Calcium Chloride; Chlormadinone Acetate; Cyclic AMP; Cyclic GMP; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; In Vitro Techniques; Jugular Veins; Levonorgestrel; Male; Norpregnenes; Potassium Chloride; Progesterone Congeners; Protein Kinase C; Rabbits; Rolipram; Tetradecanoylphorbol Acetate; Thionucleotides; Vasodilation | 2000 |
Economic analysis of long-term reversible contraceptives. Focus on Implanon.
Topics: Contraceptive Agents, Female; Cost-Benefit Analysis; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Progesterone Congeners; Vinyl Compounds | 2000 |
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Humans; Levonorgestrel; Norpregnenes; Progesterone Congeners; Risk Factors; Thromboembolism; Venous Thrombosis | 2001 |
Protein S levels are lower in women receiving desogestrel-containing combined oral contraceptives (COCs) than in women receiving levonorgestrel-containing COCs at steady state and on cross-over.
Topics: Adult; Analysis of Variance; Contraceptives, Oral, Combined; Cross-Over Studies; Desogestrel; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Protein S; Risk; Venous Thrombosis | 2001 |
[Hormonal contraception with gestagens].
Topics: Contraceptives, Oral, Synthetic; Contraceptives, Postcoital, Hormonal; Contraceptives, Postcoital, Synthetic; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Injections, Intramuscular; Levonorgestrel; Ovulation; Progesterone Congeners; Randomized Controlled Trials as Topic | 2001 |
Influence of two low-dose oral contraceptives on pulsatile gonadotropin secretion.
Topics: Adult; Contraceptives, Oral, Combined; Desogestrel; Drug Administration Schedule; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Levonorgestrel; Menstrual Cycle; Ovary; Progesterone; Reference Values | 2001 |
Oral contraceptives and the risk of myocardial infarction.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral; Desogestrel; Ethinyl Estradiol; Factor V; Female; Humans; Levonorgestrel; Logistic Models; Middle Aged; Myocardial Infarction; Norpregnenes; Odds Ratio; Point Mutation; Prothrombin; Risk Factors; Smoking | 2001 |
Update on contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Delayed-Action Preparations; Desogestrel; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Vinyl Compounds | 2000 |
Implantable contraceptives for women.
Topics: Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Levonorgestrel; Progesterone Congeners; Vinyl Compounds | 2002 |
[Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
Topics: Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Drug Information Services; Drug Prescriptions; Female; Humans; Levonorgestrel; Practice Guidelines as Topic; Progestins; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke.
Topics: Adolescent; Adult; Arterial Occlusive Diseases; Brain Ischemia; Case-Control Studies; Comorbidity; Contraceptives, Oral; Desogestrel; Dose-Response Relationship, Drug; Female; Humans; Levonorgestrel; Middle Aged; Netherlands; Norpregnenes; Odds Ratio; Risk Assessment; Risk Factors; Stroke; Surveys and Questionnaires; Thrombosis | 2002 |
Can changes in sex hormone binding globulin predict the risk of venous thromboembolism with combined oral contraceptive pills?
Topics: Biomarkers; Contraceptives, Oral, Combined; Cyproterone Acetate; Desogestrel; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Predictive Value of Tests; Risk Factors; Sex Hormone-Binding Globulin; Venous Thrombosis | 2002 |
Clinical risk factors for venous thromboembolus in users of the combined oral contraceptive pill.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Norpregnenes; Odds Ratio; Risk Factors; Thromboembolism; Venous Thrombosis | 2002 |
New developments in contraception.
Topics: Administration, Cutaneous; Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Estradiol; Female; Forecasting; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Vinyl Compounds | 2002 |
Vaginal rings for contraception: endocrine parameters.
Topics: Biology; Contraception; Contraception Behavior; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Desogestrel; Endocrine Glands; Endocrine System; Estradiol; Estrogens; Ethinyl Estradiol; Family Planning Services; Hormones; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Physiology; Progesterone; Progestins | 1992 |
Effect of combined low-dose oral contraceptives on blood viscosity and haematocrit.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Case-Control Studies; Clinical Laboratory Techniques; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Developing Countries; Diagnosis; Disease; Embolism; Ethinyl Estradiol; Family Planning Services; Hematocrit; Hematologic Tests; Levonorgestrel; Malaysia; Methods; Physiology; Research; Research Design; Thromboembolism; Thrombosis; Vascular Diseases | 1991 |
[Comparative study of the effects of three different kinds of oral contraceptives on lipoprotein and apolipoprotein metabolism].
Topics: Asia; Asia, Eastern; Biology; Cardiovascular System; China; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Desogestrel; Developing Countries; Family Planning Services; Levonorgestrel; Norethindrone; Physiology; Research | 1993 |
Pill research results in new guidance from CSM.
Topics: Biology; Communication; Consumer Product Safety; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Delivery of Health Care; Demography; Desogestrel; Developed Countries; Disease; Embolism; Europe; Evaluation Studies as Topic; Family Planning Services; Geography; Health; Health Personnel; Knowledge; Levonorgestrel; Norethindrone; Population; Public Health; Residence Characteristics; Risk Assessment; Risk Factors; Safety; Thromboembolism; Thrombosis; United Kingdom; Vascular Diseases | 1995 |
Coagulation profile in women on low-dose oral contraceptive pills.
Topics: Asia; Asia, Southeastern; Biology; Blood; Blood Coagulation; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Desogestrel; Developing Countries; Ethinyl Estradiol; Family Planning Services; Human Experimentation; Levonorgestrel; Malaysia; Physiology; Research | 1990 |
Sonographic imaging in progestin users and future directions.
Topics: Desogestrel; Endometrium; Female; Humans; Levonorgestrel; Menstruation; Ovary; Progesterone Congeners; Ultrasonography; Uterus; Vagina; Vinyl Compounds | 2002 |
Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study.
Topics: Animals; Aorta; Arteriosclerosis; Cholesterol; Contraceptives, Oral, Synthetic; Desogestrel; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Levonorgestrel; Norpregnenes; Progestins; Rabbits | 2003 |
[Acne vulgaris in connection with the use of progestagens in a hormonal IUD or a subcutaneous implant].
Topics: Acne Vulgaris; Adult; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Isotretinoin; Levonorgestrel; Progestins | 2003 |
Relationship between serum gonadotropins and spermatogenic suppression in men undergoing steroidal contraceptive treatment.
Topics: Contraceptive Agents, Male; Cyproterone Acetate; Desogestrel; Follicle Stimulating Hormone; Humans; Levonorgestrel; Logistic Models; Luteinizing Hormone; Male; Progestins; Sperm Count; Spermatogenesis; Testosterone | 2004 |
Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Delayed-Action Preparations; Desogestrel; Drug Administration Routes; Drug Implants; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Models, Economic; Prospective Studies; Treatment Failure; United Kingdom | 2004 |
Cerazette licence extension.
Topics: Adolescent; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Contraindications; Desogestrel; Family Health; Female; Humans; Levonorgestrel; Ovulation; Time Factors | 2005 |
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells.
Topics: Alkaline Phosphatase; Androstenes; Breast Neoplasms; Cell Line, Tumor; Cluster Analysis; Desogestrel; Dose-Response Relationship, Drug; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Levonorgestrel; Ligands; Medroxyprogesterone Acetate; Oligonucleotide Array Sequence Analysis; Progesterone; Progestins; Promegestone; Receptors, Estrogen; Receptors, Progesterone; Reverse Transcriptase Polymerase Chain Reaction; RNA; Transcription, Genetic | 2005 |
Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
Topics: Adolescent; Adult; Clinical Trials as Topic; Contraceptive Devices, Female; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Pregnancy; Treatment Outcome | 2006 |
Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Topics: Adolescent; Adult; Case-Control Studies; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Databases, Factual; Desogestrel; Female; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Odds Ratio; Risk Factors; Thromboembolism | 2006 |
Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Topics: Administration, Cutaneous; Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Desogestrel; Female; Humans; Intracranial Thrombosis; Levonorgestrel; Norgestrel; Risk; Sinus Thrombosis, Intracranial | 2006 |
Response of the female vocal quality and resonance in professional voice users taking oral contraceptive pills: a multiparameter approach.
Topics: Adult; Androstenes; Contraceptives, Oral, Synthetic; Desogestrel; Female; Humans; Levonorgestrel; Menstrual Cycle; Menstruation; Norpregnenes; Phonation; Speech Acoustics; Voice; Voice Disorders; Voice Quality | 2006 |
The long-term actions of etonogestrel and levonorgestrel on decidualized and non-decidualized endometrium in a mouse model mimic some effects of progestogen-only contraceptives in women.
Topics: Animals; Contraceptive Agents, Female; Decidua; Desogestrel; Electrophoresis, Polyacrylamide Gel; Endometrium; Estrogen Receptor alpha; Female; Immunohistochemistry; Intrauterine Devices, Medicated; Killer Cells, Natural; Levonorgestrel; Macrophages; Matrix Metalloproteinase 3; Matrix Metalloproteinase 7; Matrix Metalloproteinase 9; Metrorrhagia; Mice; Mice, Inbred C57BL; Models, Animal; Neutrophils; Organ Size; Receptors, Progesterone; Time Factors; Uterus | 2007 |
High performance liquid chromatography/ion-trap mass spectrometry for separation and simultaneous determination of ethynylestradiol, gestodene, levonorgestrel, cyproterone acetate and desogestrel.
Topics: Chromatography, High Pressure Liquid; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Levonorgestrel; Norpregnenes; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet | 2007 |
Simultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosis.
Topics: Adolescent; Contraceptive Agents, Female; Desogestrel; Drug Implants; Endometriosis; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Pelvic Pain | 2007 |
Study of low-density lipoprotein receptor regulation by oral (steroid) contraceptives: desogestrel, levonorgestrel and ethinyl estradiol in JEG-3 cell line and placental tissue.
Topics: Cell Line, Tumor; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Humans; Levonorgestrel; Placenta; Receptors, LDL; Up-Regulation | 2007 |
Different effects of oral contraceptives containing different progestogens on protein S and tissue factor pathway inhibitor.
Topics: Activated Protein C Resistance; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Levonorgestrel; Lipoproteins; Middle Aged; Protein S; Thrombophilia | 2008 |
The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
Topics: Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Decision Trees; Desogestrel; Drug Administration Routes; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Medroxyprogesterone; Models, Theoretical; Practice Guidelines as Topic; Sterilization, Tubal; Time Factors; United Kingdom | 2008 |
Migraine and risk of stroke. For contraception try IUDs ...
Topics: Brain Ischemia; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Migraine with Aura; Risk Factors; Stroke | 2009 |
Contraceptive implants.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Drug Monitoring; Female; Humans; Levonorgestrel; Menorrhagia; Obesity; Pelvic Pain | 2010 |
Contraceptive options for women in selected circumstances.
Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult | 2010 |
Effects of two different low-dose oral contraceptives on plasma homocysteine levels.
Topics: Adolescent; Adult; Contraceptives, Oral; Cross-Sectional Studies; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Homocysteine; Humans; Levonorgestrel; Young Adult | 2011 |
Levonorgestrel, not etonogestrel, provides contraception in free-ranging koalas.
Topics: Analysis of Variance; Animals; Animals, Wild; Contraception; Contraceptive Agents, Female; Desogestrel; Estrous Cycle; Female; Levonorgestrel; Phascolarctidae; Population Control; Pregnancy; Progesterone; Radioimmunoassay | 2010 |
Oral contraceptives and the risk of gallbladder disease: a comparative safety study.
Topics: Adult; Androstenes; Cholecystectomy; Confidence Intervals; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Gallbladder Diseases; Humans; Levonorgestrel; Progestins; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors | 2011 |
Progestins possess poor anti-estrogenic activity on murine hepatic coagulation gene transcription despite evident anti-estrogenic activity on uterine tissue.
Topics: Animals; Blood Coagulation; Contraceptives, Oral; Desogestrel; Estrogen Antagonists; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Mice; Mice, Inbred C57BL; Receptors, Estrogen; Receptors, Progesterone; Transcription, Genetic; Uterus | 2011 |
ACOG Practice Bulletin No. 121: Long-acting reversible contraception: Implants and intrauterine devices.
Topics: Abortion, Induced; Abortion, Spontaneous; Actinomyces; Antibiotic Prophylaxis; Bone Density; Breast Feeding; Cervix Uteri; Contraceptive Agents, Female; Copper; Desogestrel; Device Removal; Female; Humans; Intrauterine Devices; Intrauterine Devices, Medicated; Levonorgestrel; Menopause; Menstrual Cycle; Postpartum Period; Pregnancy; Pregnancy Outcome; Pregnancy, Ectopic; Sexually Transmitted Diseases | 2011 |
Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.
Topics: Adolescent; Adult; Androstenes; Anticoagulants; Cohort Studies; Confounding Factors, Epidemiologic; Contraceptives, Oral; Denmark; Desogestrel; Dose-Response Relationship, Drug; Epidemiologic Methods; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnenes; Pregnancy; Time Factors; Venous Thromboembolism; Young Adult | 2011 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |
Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study.
Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Progesterone Congeners; Qualitative Research | 2012 |
Guidelines for the use of long-acting reversible contraceptives.
Topics: Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Practice Guidelines as Topic; Pregnancy | 2012 |
Differences in prescription rates and odds ratios of antidepressant drugs in relation to individual hormonal contraceptives: a nationwide population-based study with age-specific analyses.
Topics: Adolescent; Adult; Age Distribution; Antidepressive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Drug Utilization; Female; Humans; Levonorgestrel; Logistic Models; Lynestrenol; Medroxyprogesterone; Norgestrel; Odds Ratio; Oximes; Population Surveillance; Practice Patterns, Physicians'; Registries; Sweden | 2012 |
Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
Topics: Adolescent; Adolescent Behavior; Adolescent Health Services; Confidentiality; Contraceptive Agents, Female; Desogestrel; Directive Counseling; Female; Humans; Informed Consent By Minors; Intrauterine Devices, Medicated; Levonorgestrel; Patient Acceptance of Health Care; Pregnancy; Pregnancy in Adolescence; Sexual Behavior; United States | 2012 |
Endometrial histopathology, ovarian changes and bleeding patterns among users of long-acting progestin-only contraceptives in Egypt.
Topics: Adult; Amenorrhea; Contraceptive Agents, Female; Desogestrel; Dose-Response Relationship, Drug; Egypt; Endometrium; Female; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Ovarian Follicle; Progestins; Time Factors; Ultrasonography | 2012 |
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Topics: Administration, Cutaneous; Age Factors; Aged; Case-Control Studies; Contraceptives, Oral, Hormonal; Desogestrel; Estradiol; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Netherlands; Norethindrone; Norethindrone Acetate; Odds Ratio; Postmenopause; Progestins; Risk Assessment; Risk Factors; Sex Factors; Transdermal Patch; Venous Thrombosis | 2013 |
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives.
Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors | 2013 |
Formulation and optimization of desogestrel transdermal contraceptive patch using crystallization studies.
Topics: Adhesives; Animals; Contraceptives, Oral, Synthetic; Crystallization; Desogestrel; Excipients; Levonorgestrel; Male; Mineral Oil; Pyrrolidines; Rats; Rats, Hairless; Reproducibility of Results; Skin Absorption; Solubility; Transdermal Patch; Vinyl Compounds | 2013 |
Effects of progestin-only long-acting contraception on metabolic markers in obese women.
Topics: Animals; Biomarkers; Blood Glucose; Blood Pressure; Cholesterol, HDL; Contraceptive Agents, Female; Desogestrel; Fasting; Female; Insulin; Insulin Resistance; Insulin-Secreting Cells; Intrauterine Devices, Medicated; Levonorgestrel; Metabolic Syndrome; Obesity; Progestins; Prospective Studies; Waist Circumference | 2013 |
Newer non-oral hormonal contraception.
Topics: Administration, Cutaneous; Contraceptive Agents, Female; Contraceptive Devices, Female; Desogestrel; Drug Combinations; Drug Implants; Drug Monitoring; Ethinyl Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Norgestrel; Safety; Treatment Outcome | 2013 |
Weight change at 12 months in users of three progestin-only contraceptive methods.
Topics: Adolescent; Adult; Black or African American; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Follow-Up Studies; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone Acetate; Missouri; Progestins; Prospective Studies; Urban Health; Weight Gain; Young Adult | 2013 |
Impact of combined oral contraceptives containing ethinylestradiol on the liver microsomal metabolism.
Topics: Acetamides; Adult; Androstenes; Breath Tests; Carbon Radioisotopes; Case-Control Studies; Contraceptives, Oral, Combined; Cyproterone Acetate; Cytochrome P-450 CYP1A2; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Liver; Menstrual Cycle; Norgestrel; Norpregnenes; Young Adult | 2013 |
The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis.
Topics: Adolescent; Androstenes; Child; Chlormadinone Acetate; Contraceptive Agents; Desogestrel; Drug Prescriptions; Drug Utilization; Female; Germany; Gynecology; Humans; Levonorgestrel; Menstruation Disturbances; Practice Patterns, Physicians'; Pregnancy; Pregnancy in Adolescence; Retrospective Studies | 2013 |
A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Topics: Adult; Age Factors; Amenorrhea; Australia; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Longitudinal Studies; Marital Status; Metrorrhagia; Parity; Patient Satisfaction; Young Adult | 2014 |
Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
Topics: Adult; Contraception; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; France; Humans; Intrauterine Devices, Medicated; Ireland; Levonorgestrel; Longitudinal Studies; Middle Aged; Patient Acceptance of Health Care; Prospective Studies; Slovakia; United Kingdom; Young Adult | 2014 |
Effect of progestins on immunity: medroxyprogesterone but not norethisterone or levonorgestrel suppresses the function of T cells and pDCs.
Topics: Adult; Cells, Cultured; Contraceptive Agents, Female; Cytokines; Delayed-Action Preparations; Dendritic Cells; Desogestrel; Female; HIV-1; Humans; Imidazoles; Immune Tolerance; Levonorgestrel; Lymphocyte Activation; Lymphocytes; Medroxyprogesterone Acetate; Norethindrone; Oligodeoxyribonucleotides; Progestins; Toll-Like Receptor 9; Toll-Like Receptors | 2014 |
Long acting reversible contraception in adolescents with cardiovascular conditions.
Topics: Adolescent; Cardiovascular Diseases; Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Device Expulsion; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Menorrhagia; Retrospective Studies; Young Adult | 2014 |
Provision of no-cost, long-acting contraception and teenage pregnancy.
Topics: Abortion, Induced; Adolescent; Birth Rate; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Pregnancy; Pregnancy in Adolescence; Prospective Studies; United States; Young Adult | 2014 |
Complications and continuation rates associated with 2 types of long-acting contraception.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Patient Compliance; Retrospective Studies; Subcutaneous Tissue; Young Adult | 2015 |
Use of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Prospective Studies; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2015 |
Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
Topics: Abortion, Induced; Adolescent; Adult; Body Weight; Choice Behavior; Contraception; Contraceptive Agents, Female; Decision Making; Desogestrel; Drug Implants; Educational Status; Female; Humans; Intimate Partner Violence; Intrauterine Devices, Medicated; Levonorgestrel; Logistic Models; Medroxyprogesterone Acetate; Middle Aged; Multivariate Analysis; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Racial Groups; Stress, Psychological; Young Adult | 2015 |
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception.
Topics: Adipose Tissue; Basal Metabolism; Body Composition; Calorimetry, Indirect; Case-Control Studies; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Middle Aged; Perimenopause; Progestins | 2016 |
Low-dose progestin-releasing contraceptives are associated with a higher pain threshold in healthy women.
Topics: Adult; Case-Control Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cross-Sectional Studies; Desogestrel; Drug Implants; Estradiol; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Luteinizing Hormone; Medroxyprogesterone; Menstrual Cycle; Pain Measurement; Pain Threshold; Pressure; Progesterone; Progestins; Psychometrics; Surveys and Questionnaires; Testosterone; Young Adult | 2015 |
Use pattern for contraceptive implants in Norway.
Topics: Adolescent; Adult; Contraception; Contraception Behavior; Contraceptive Agents, Female; Cross-Sectional Studies; Databases, Factual; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Middle Aged; Norway; Practice Patterns, Physicians'; Young Adult | 2016 |
Changes in body composition in women using long-acting reversible contraception.
Topics: Adult; Analysis of Variance; Body Composition; Body Mass Index; Body Weight; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Linear Models; Prospective Studies; Young Adult | 2017 |
Prolonged use of the etonogestrel implant and levonorgestrel intrauterine device: 2 years beyond Food and Drug Administration-approved duration.
Topics: Adolescent; Adult; Body Mass Index; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Middle Aged; Pregnancy; Pregnancy, Unplanned; Prospective Studies; Time Factors; United States; United States Food and Drug Administration; Young Adult | 2017 |
Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: a retrospective review.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Delivery of Health Care; Desogestrel; Drug Implants; Female; Hispanic or Latino; Humans; Intrauterine Devices; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Reimbursement Mechanisms; Retrospective Studies; Time Factors; Young Adult | 2017 |
Thromboembolic adverse event study of combined estrogen-progestin preparations using Japanese Adverse Drug Event Report database.
Topics: Adolescent; Adult; Adverse Drug Reaction Reporting Systems; Androstenes; Child; Contraceptives, Oral, Combined; Databases, Factual; Desogestrel; Drug-Related Side Effects and Adverse Reactions; Estrogens; Ethinyl Estradiol; Female; Humans; Japan; Levonorgestrel; Male; Middle Aged; Norethindrone; Norgestrel; Odds Ratio; Progestins; Thromboembolism; Young Adult | 2017 |
Extended Effectiveness of the Etonogestrel-Releasing Contraceptive Implant and the 20 µg Levonorgestrel-Releasing Intrauterine System for 2 Years Beyond U.S. Food and Drug Administration Product Labeling.
Topics: Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Product Labeling; Randomized Controlled Trials as Topic; Time Factors; United States; United States Food and Drug Administration | 2017 |
Is Shifting to a Progestin Worthwhile When Estrogen-Progestins Are Inefficacious for Endometriosis-Associated Pain?
Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Desogestrel; Endometriosis; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Patient Satisfaction; Pelvic Pain; Progestins; Prospective Studies; Quality of Life; Treatment Outcome; Young Adult | 2018 |
Impact of contraceptive initiation on vaginal microbiota.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult | 2018 |
Influence of age on tolerability, safety and effectiveness of subdermal contraceptive implants.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Device Removal; Drug Implants; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Menstruation; Retrospective Studies; Young Adult | 2018 |
Two-year contraceptive continuation rates among immediate postpartum implant users at a district hospital in Malawi: a prospective cohort study.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Desogestrel; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Malawi; Postnatal Care; Prospective Studies; Young Adult | 2018 |
Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women.
Topics: Administration, Oral; Adult; Androgen Antagonists; Androstenes; Cohort Studies; Contraceptive Agents, Female; Desogestrel; Europe; Female; Humans; Levonorgestrel; Logistic Models; Long QT Syndrome; Norpregnenes; Sotalol; Young Adult | 2018 |
Esters of levonorgestrel and etonogestrel intended as single, subcutaneous-injection, long-lasting contraceptives.
Topics: Animals; Contraceptive Agents, Female; Desogestrel; Esters; Female; Injections, Subcutaneous; Levonorgestrel; Ovulation; Rats; Rats, Sprague-Dawley | 2018 |
Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Topics: Adenomyosis; Adult; China; Desogestrel; Dysmenorrhea; Endometriosis; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Subcutaneous; Levonorgestrel; Luteinizing Hormone; Middle Aged; Uterus | 2018 |
[Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Topics: Androstenes; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Desogestrel; Female; France; Humans; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Vascular Diseases; Venous Thromboembolism | 2018 |
Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood.
Topics: Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Receptors, CCR5; Receptors, CXCR4; T-Lymphocytes; Young Adult | 2019 |
[Long-acting reversible contraception methods in the Brazilian Unified National Health System: the debate on women's (in)discipline].
Topics: Adolescent; Brazil; Contraception, Postcoital; Contraceptive Agents, Female; Desogestrel; Family Planning Services; Female; Humans; Levonorgestrel; Long-Acting Reversible Contraception; National Health Programs; Time Factors; Young Adult | 2019 |
An exploratory study of the perception of contraceptive safety and impact on lactation among postpartum nurses at Women and Infants Hospital in 2017.
Topics: Adult; Contraception; Contraceptive Agents, Female; Desogestrel; Female; Health Knowledge, Attitudes, Practice; Hospitals, Maternity; Humans; Intrauterine Devices; Lactation; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Middle Aged; Nurses; Practice Patterns, Nurses'; Rhode Island; Young Adult | 2019 |
Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission.
Topics: Adolescent; Adult; Cervix Uteri; Contraception; Contraceptive Agents, Female; Desogestrel; Female; HIV Infections; Humans; Levonorgestrel; Medroxyprogesterone Acetate; Progestins; Young Adult | 2019 |
Comparison of weight gain between levonorgestrel and etonogestrel implants after 12 months of insertion.
Topics: Adult; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Prospective Studies; Time Factors | 2019 |
A pharmacokinetic and pharmacogenetic evaluation of contraceptive implants and antiretroviral therapy among women in Kenya and Uganda.
Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Contraceptive Agents, Female; Cyclopropanes; Desogestrel; Drug Antagonism; Female; HIV Infections; Humans; Kenya; Levonorgestrel; Linear Models; Nevirapine; Pharmacogenomic Testing; Uganda | 2019 |
Unprotected intercourse in the 2 weeks prior to quick-start initiation of an etonogestrel contraceptive implant with and without use of oral emergency contraception.
Topics: Adolescent; Adult; Contraception, Postcoital; Contraceptive Agents, Hormonal; Contraceptives, Postcoital; Desogestrel; Drug Implants; Female; Humans; Levonorgestrel; Norpregnadienes; Pregnancy; Pregnancy Tests; Risk Assessment; Time Factors; Unsafe Sex; Young Adult | 2020 |
Comparison of contraceptive failures associated with CYP3A4-inducing drug-drug interactions by route of hormonal contraceptive in an adverse event reporting system.
Topics: Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Effectiveness; Cytochrome P-450 CYP3A; Desogestrel; Drug Implants; Drug Interactions; Female; Humans; Levonorgestrel; Pharmaceutical Preparations; Pregnancy | 2021 |
Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
Topics: Adolescent; Aftercare; Case-Control Studies; Contraception Behavior; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices; Levonorgestrel; Long-Acting Reversible Contraception; Office Visits; Patient Compliance; Retrospective Studies | 2021 |
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Contraceptives, Oral; Cost-Benefit Analysis; Desogestrel; Drug Administration Routes; Female; France; Humans; Levonorgestrel; Long-Acting Reversible Contraception; Middle Aged; Models, Economic; Pregnancy; Young Adult | 2021 |
Adolescent contraception.
Topics: Adolescent; Bone Density; Canada; Contraception; Contraceptive Agents, Female; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Levonorgestrel; Long-Acting Reversible Contraception; Medroxyprogesterone Acetate; Pregnancy; Pregnancy, Unplanned; Sexually Transmitted Diseases | 2021 |
Female sexual function in women using LARC methods.
Topics: Adult; Contraceptive Agents, Female; Cross-Sectional Studies; Desogestrel; Female; Humans; Intrauterine Devices, Copper; Intrauterine Devices, Medicated; Levonorgestrel; Quality of Life; Sexual Dysfunction, Physiological | 2022 |
Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports.
Topics: Adenomyosis; Desogestrel; Endometrial Ablation Techniques; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel | 2022 |
Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study.
Topics: Breast Neoplasms; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Estrogens; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Nurses; Progestins; Prospective Studies | 2022 |
Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case-control analysis using German claims data.
Topics: Case-Control Studies; Chlormadinone Acetate; Contraceptives, Oral, Combined; Desogestrel; Female; Humans; Levonorgestrel; Risk Factors; Venous Thromboembolism | 2022 |
Pharmacokinetics of levonorgestrel and etonogestrel in rat or minipig following intravenous, subcutaneous, or intradermal administration.
Topics: Animals; Contraceptive Agents; Desogestrel; Levonorgestrel; Rats; Rats, Sprague-Dawley; Swine; Swine, Miniature | 2022 |